Geographic Distribution of Lyme Borreliosis in North America by Herrin, Brian Hale
   GEOGRAPHIC DISTRIBUTION OF LYME 
BORRELIOSIS IN NORTH AMERICA 
 
 
   By 
      BRIAN H. HERRIN 
   Bachelor of Science in Agricultural Sciences and Natural 
Resources  
   Oklahoma State University 
   Stillwater, OK 
   2009 
 
   Doctor of Veterinary Medicine  
   Oklahoma State University 
   Stillwater, OK 
   2014 
 
 
   Submitted to the Faculty of the 
   Graduate College of the 
   Oklahoma State University 
   in partial fulfillment of 
   the requirements for 
   the Degree of 
   DOCTOR OF PHILOSOPHY 
   July, 2016  
ii 
 
   GEOGRAPHIC DISTRIBUTION OF LYME 
BORRELIOSIS IN NORTH AMERICA 
 
 
   Dissertation Approved: 
 
Dr. Susan Little    
  Dissertation Adviser 
Dr. Mason Reichard    
 
Dr. Edward Shaw    
 
Dr. Gilbert John 
iii 
Acknowledgements reflect the views of the author and are not endorsed by committee 
members or Oklahoma State University. 
ACKNOWLEDGEMENTS 
 
 
 
 I am humbled to have had an amazing network of faculty, colleagues, friends and 
family support me on this journey. First, a special thanks to Dr. Susan Little, who has not 
only helped me grow my technical and knowledge skills, but also my networking, public 
speaking, teaching, and other professional skills that have allowed me to progress in my 
career.  Her continued support of my work since I was an undergraduate has meant the 
world to me.  
 Many other faculty members throughout Oklahoma State University have aided in 
my growth as a scientist, especially those taking time to serve as my committee members 
and mentors, Drs. Ed Shaw, Mason Reichard, and Gilbert John. From the initial support 
as an undergraduate looking to do research to today, these mentors have challenged me to 
excel and provided me with the necessary feedback to grow as a young professional. 
 I could not have made it through my graduate work without the support of the 
members of the Krull-Ewing laboratory. The mentoring I received early in my career 
from Drs. Kelly Allen and Stephanie Heise was instrumental in providing a strong 
research foundation. Drs. Lindsay Starkey and Anne Barrett added to that foundation as 
we bounced our problems and ideas off each other and learned together. Throughout this 
time, Jeff Gruntmeir has been keep us all on track. He is a master of all techniques and 
can optimize any protocol. Without his support, myself and our lab would not be as
iv 
Acknowledgements reflect the views of the author and are not endorsed by committee 
members or Oklahoma State University. 
 successful as we are.  
 Finally, I want to thank my family and friends for their continued support. My 
parents have encouraged me to work hard, explore the world, and say, “YES!” to 
opportunity, all while allowing me to make these decisions on my own. They still may 
have no idea why someone is willing to pay me to “catch ticks”, but they support me with 
love and without judgement. None of this is possible without them. My friends have been 
instrumental in preserving my sanity during my graduate work. Throughout the highs and 
lows, they provide support, advice and friendship that fostered my success. 
v 
 
Name: BRIAN H HERRIN   
 
Date of Degree: JULY, 2016 
  
Title of Study: GEOGRAPHIC DISTRIBUTION OF LYME BORRELIOSIS IN 
NORTH AMERICA 
 
Major Field: VETERINARY BIOMEDICAL SCIENCES 
 
Abstract:  
 
The research presented in this dissertation was conducted using canine serology as a tool 
to further the characterization of Lyme endemic regions of North America. In chapter 3, 
targeted tick testing in southwestern Virginia was implemented to validate canine 
serology showing an expansion of the Lyme endemic region from the north. All 364 ticks 
were morphologically and molecularly identified as Ixodes scapularis, and 33% tested 
positive for Borrelia burgdorferi sensu stricto by PCR. Canine serology was again 
utilized (Chapter 4) to describe environments where dogs, and thus humans, were most 
likely to be exposed to B. burgdorferi around the New York City Metropolitan Area. In 
this study environmental and social variables were organized by county and compared to 
prevalence of positive canine serologic tests and human case reports. The data showed 
that human case reports and canine antibody prevalence increased, radiating outward 
from areas of dense development in a manner that corresponded with higher percent 
forested areas. When the environmental factors were further probed, a more complete 
description of the habitat, which represented a higher risk of infection, corresponded 
more closely to canine serology than human case reports. The third study (Chapter 5) was 
a serosurvey of common vector-borne disease agents of dogs across Canada, namely 
Borrelia burgdorferi, Dirofilaria immitis, Anaplasma spp., and Ehrlichia spp. Prevalence 
of antibodies to B. burgdorferi across all samples tested was 2.5% while the other vector-
borne agents had a positive prevalence less than 0.5%. The serologic prevalence of 
antibodies to B. burgdorferi in several provinces, including Nova Scota, New Brunswick, 
southern Quebec, and eastern Ontario, were similar to those seen in Lyme endemic areas 
of the US, reaffirming the disease’s endemnicity in these regions of Canada. In summary, 
canine serology is a useful tool for mapping endemic areas of Lyme borreliosis, 
documenting the expansion of the endemic range, and describing the environments that 
support the greatest risk of infection to humans and dogs. 
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CHAPTER I 
 
 
INTRODUCTION 
 Lyme borreliosis (LB) is the most commonly diagnosed vector-borne 
disease of people in the United States with around 30,000 cases reported in humans each 
year (CDC, 2015). Borrelia burgdorferi, the causative agent of LB in the US, was first 
discovered in the Northeast by Dr. Willy Burgdorfer, but since then the identified range 
of both the tick vector and pathogen has expanded (Hayes et al., 1983; Ogden et al., 
2006). The bacteria are transmitted by Ixodes scapularis in the Upper Midwest and 
Northeast regions of the US and southern Canada, and by I. pacificus on the West Coast 
(Diuk-Wasser et al., 2012; Lane et al., 1998). Based on existing survey data of dogs and 
case reports in people, the Northeast and Upper Midwest regions of the US represent an 
increased risk for infection with B. burgdorferi sensu stricto in comparison to the rest of 
the United States (Little et al., 2014; CDC, 2015).  
Accurate diagnosis of LB can be challenging. A classic erythema migrans, or 
bulls-eye rash, is seen in most, but not all, human patients during acute infection 
(Nadelman, 2015). When infection persists and spirochetes disseminate, arthralgia, 
carditis, or neurologic disease may develop. Laboratory confirmation of LB in humans 
requires two-tiered serologic testing that can complicate clinical diagnosis (Marques, 
2010). Because of the diagnostic complexities, accurate mapping of 
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the risk of infection based on human case reports alone is challenging, therefore active and 
passive surveillance for the pathogen in wildlife, ticks, and domestic animals is key to 
determining the endemic range (Duncan et al., 2005; Ostfeld et al., 2006; Werden et al., 
2014). 
Due to recent changes in climate and habitat, the range of the I. scapularis / B. 
burgdorferi maintenance system has spread, resulting in expansion of the historic endemic 
foci in the Upper Midwest and northeastern United States (Diuk-Wasser et al., 2012; Hamer 
et al., 2009; Ogden et al., 2006). A major driver of this expansion is the overall increase in 
temperatures, which has facilitated the incursion of ticks harboring the pathogen into Canada 
(Ogden et al., 2014). In addition to climate, habitat factors play a key role in not only 
supporting the tick populations, but also supporting the wildlife reservoirs for the bacteria 
and the ticks. In general, an increase in the density of green plants on a patch of land, 
especially deciduous (oak and maple) forests, correlates with higher I. scapularis density 
(Ogden et al., 2006; Guerra et al., 2002). These forested areas provide suitable habitat for the 
rodents and small mammals that immature I. scapularis prefer and white-tailed deer that 
support the adult ticks (Brunner et al., 2008; Kilpatrick et al., 2014). Since forested regions, 
rodents, white-tailed deer, and even I. scapularis are found in a much broader range than that 
of Lyme disease, there appear to be other factors that promote or hinder the maintenance of  
Borrelia burgdorferi in nature (IUCN, 2008; Nelder et al., 2016). The phenology of I. 
scapularis in the southern United States appears to be different than that of this species in the 
Northeast and Upper Midwest. These two populations have different host-seeking behavior, 
feeding preferences, and duration of attachment to hosts, and therefore, while ticks from both 
regions have been shown to be competent vectors, in nature, only the northern populations 
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are directly associated with cases of LB in humans and dogs (Oliver et al., 1993; Goddard 
1992; Arsnoe et al., 2015). 
Identifying ideal habitats for maintenance of the pathogen in nature allows for 
prediction of risk of infection within a region. Furthermore, canine serology may also 
provide valuable information on endemic range and high-risk habitats (Guerra et al., 2001; 
Duncan et al., 2005). Similar to all vector-borne pathogens, B. burgdorferi transmission and 
maintenance requires a complex assortment of interconnected environmental, climatic, and 
physiologic variables to be efficient (Ogden et al., 2013). Identification of these factors 
should allow prediction of the expansion of areas where LB is endemic and provide an 
opportunity to prevent future infections.   
 The proposed research uses canine seroprevalence to B. burgdorferi, along with 
targeted tick collection and testing, to define the range of LB in North America. Ultimately, 
this knowledge of the expanding endemic range will allow for more accurate diagnosis of 
cases of LB and describe environments that may be able to support this maintenance cycle in 
the future.  
 To better define and describe the areas where autochthonous transmission of Borrelia 
burgdorferi sensu stricto is documented to occur in North America, a series of studies were 
undertaken: 
 
1) Identify Borrelia burgdorferi sensu stricto in resident populations of Ixodes scapularis 
in a historically non-endemic but suspected newly emergent area for Lyme borreliosis, 
southwest Virginia.  
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Based on canine serology reported over several years, it appeared the endemic range 
for Borrelia burgdorferi was expanding into southern Virginia along the Appalachian 
Mountains (Bowman et al., 2009; Little et al., 2014). In our study, ticks were collected from 
October 2012 to April 2013 by standard drag techniques from three wooded park or 
residential sites and subsequently tested for B. burgdorferi and Anaplasma phagocytophilum. 
Both tick identification and infection status were confirmed by PCR and sequencing of their 
respective DNA products. A total of 364 adult ticks were collected, all of which were 
morphologically and molecularly identified as Ixodes scapularis. The presence of B. 
burgdorferi sensu stricto was molecularly confirmed in 117/356 (33%) ticks tested, while 
only 3/364 (0.8%) ticks tested positive for A. phagocytophilum. This study represented the 
first description of I. scapularis along this portion of the Appalachian Region as well as 
documenting the southern expansion of the northern clade of I. scapularis (Oliver et al., 
1988). These data also show that the pathogen prevalence of B. burgdorferi and A. 
phagocytophilum are similar to areas previously considered to be endemic for Lyme disease, 
further pointing to the expansion of vector and pathogen range from the Northeast.  
 
2) Determine the environmental and social variables associated with infection with 
Borrelia burgdorferi in humans and dogs in the New York City Metropolitan Statistical 
Area.  
Dogs have been shown to be sentinels for infection with tick-borne diseases, 
including Borrelia burgdorferi in endemic areas of the United States (Guerra et al., 2001; 
Mead et al., 2011; Duncan et al., 2005). In this study, the New York City Metropolitan 
Statistical Area (NYC MSA), a region of varying habitat and demographic diversity, was 
selected to determine if canine serology, along with environmental and social factors, could 
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identify areas where humans are at risk for infection with B. burgdorferi. Percent positive 
canine test results for B. burgdorferi, human case reports of LB, and social and 
environmental factors were all collected at a county level, and the variables were compared 
with canine serology and human case reports first by categorical analysis and then by 
multiple regression. The categorical analysis revealed a gradient of increasing prevalence 
radiating outwards corresponding to an increase in forested area, with the highest prevalence 
being 21.1%. The environmental risk factors derived from the regressions provided an 
accurate description of areas where dogs are at risk of infection in the area (R2=0.90), but 
was less accurate at describing environments that correlate with human case reports 
(R2=0.74). These data confirmed that, in endemic areas, canine serology can be utilized to 
describe areas where infection with B. burgdorferi is most likely to occur. 
 
3) Define the extent of Lyme borreliosis expansion into Canada using serologic 
detection of antibodies to Borrelia burgdorferi in dogs   
Surveillance of several common vector-borne infections in dogs has been a useful 
tool for monitoring changes in prevalence in the United States over the past 10 years 
(Bowman et al., 2009; Little et al., 2014). Veterinarians throughout Canada have begun 
annual screening of canine patients for antibodies to Ehrlichia spp., B. burgdorferi and 
Anaplasma spp., and to Dirofilaria immitis antigen, and the percent positive canine test 
results have been organized into a national reporting system maintained by IDEXX 
Laboratories, Inc. (Westbrook, ME) from 2012-2014. Test results were grouped by three-
digit Canadian postal code or by major city of the veterinary hospital submitting the sample. 
The national prevalence of antibodies to B. burgdorferi was 2.5% (2,844/1115,636), while 
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none of the other three test analytes yielded a prevalence for past or current infection with the 
corresponding disease agent above 0.5%. In addition, areas of endemic or hyperendemic LB 
was described in Nova Scotia (15.7%), eastern Ontario (5.1%), New Brunswick (3.7%), and 
Quebec (2.8%). Continued surveillance of these vector-borne infections throughout Canada 
will be important as climate, vector range, and habitat continue to change.  
 
SUMMARY 
  These studies show the utility of large scale surveillance for common vector-borne 
disease agents by documenting the expansion of the endemic range of LB in dogs, correlating 
environmental risk factors with canine serology, and documenting the incursion and 
endemnicity of B. burgdorferi in Canada. Taken together these studies provide a better 
description of the endemic area of LB in North America as well as the environmental factors 
that are key to maintaining the disease in nature. First, the population of northern clade I. 
scapularis appears to be expanding southward along the Appalachian Mountains as well as 
northward into Canada. Additionally, our data show that canine serology to B. burgdorferi is 
better represented by environmental risk factors than human case reports of LB. Lastly, our 
description of areas of endemic LB in Canada provides a base for environmental and 
temporal studies to describe the expansion of the maintenance system for B. burgdorferi 
north of its historic range.  
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
BORRELIA SPP. IN NORTH AMERICA 
 The taxonomic family Spirochaetaceae contains six genera of spirochetes, 
including Borrelia and Treponema. Borrelia spp. are gram-negative, spiral-curved 
bacteria with a unique double stranded linear chromosome approximately 900kbp and 
multiple linear and circular plasmids (Groshong et al., 2014). The genus contains 36 
species, three of which are considered to be the causative agents for Lyme borreliosis 
(LB) in different parts of the world, B. burgdorferi sensu stricto (hereafter referred to as 
B. burgdorferi) in North America, and B. afzelii and B. garinii in Europe and Asia 
(Rudenko et al., 2011). These three species together with phylogenetically related, low- 
or non-pathogenic species are grouped together under the term Borrelia burgdorferi 
sensu lato (s.l.) complex which, in North America, also includes B. americana, B. 
andersonii, B. bissettii, B. californiensis, B. carolinensis, B. kurtenbachii, and 
Genomospecies 2 (Rudenko et al., 2011). B. burgdorferi s.s. is considered to be the only 
causative agent of LB in North America, and like the B. burgdorferi s.l. complex, is 
vectored by Ixodes sp. ticks. Ixodes scapularis is the main vector for LB in midwestern 
and northeastern United States and southeast Canada, while I. pacificus is the 
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predominant vector along the West Coast. Using multilocus sequence typing (MLST), B. 
burgdorferi sensu stricto has been shown to have three genetically divergent populations 
corresponding with the tick populations in the Northeast, Upper Midwest, and West 
Coast, respectively.   
A second large grouping of Borrelia spp. includes those known as or related to 
the relapsing fever agents, which include B. hermsii, B. miyamotoi, B. parkeri, B. 
lonestari, and B. turicatae. These species are vectored by a wide variety of hard and soft 
ticks throughout the US and are considered to be distinct from the B. burgdorferi sensu 
lato complex although one of them, B. miyamotoi, is transmitted to people by the same I. 
scapularis vector tick. Borrelia hermsii, B. turicatae, and B. lonestari infections have 
been confirmed in dogs by blood film examination or PCR of whole blood (Whitney et 
al., 2007; Kelly et al., 2014; Fryxell et al., 2012). One of the main clinical differences 
between these relapsing fever agents and B. burgdorferi s.s. is the ability to detect the 
spirochetes by microscopy in blood samples during febrile episodes (Dworkin et al., 
2008).  In addition to this group, a newly described Borrelia sp., candidatus B. mayonii, 
has been detected in humans by PCR of whole blood or synovial fluid and visualization 
on blood smear for one patient (Pritt et al., 2016). While the detection of spirochetes in 
blood is only associated with relapsing fever Borrelia spp., the newly described B. 
mayonii is most genetically similar to other sensu lato Borrelia spp. such as B. 
kurtenbachii, B. caronlinensis, and B. bissettii (Pritt et al., 2016). Future efforts to 
identify additional novel Borrelia spp. are warranted. 
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IXODES SPP. IN NORTH AMERICA 
 The taxonomic family Ixodidae consists of all the hard ticks, which in North 
America include the genera Amblyomma, Dermacentor, Haemaphysalis, Ixodes, and 
Rhipicephalus. The genus Ixodes contains 246 species, approximately 30 of which are 
found in North America. Historically, what is currently called Ixodes scapularis was 
separated into two distinct species, I. scapularis Say and I. dammini (Jackson et al., 1970; 
Spielman et al., 1979). Since then, the two species have been redescribed as a single 
species, I. scapularis. This consolidation was demonstrated using both interbreeding and 
molecular techniques (Oliver Jr et al., 1993; Wesson et al., 1993).  By comparing 
sequences of the internal transcribed spacer (ITS) region of the gene for the 18S and 28S 
ribosomal subunits, Oliver et al. showed that there was more variation within populations 
of I. scapularis from the southern United States than between populations of I. scapularis 
and I. dammini (Wesson et al., 1993). Both molecular confirmation and successful 
interbreeding determined that genetically homogenous I. scapularis populations in the 
North were geographically isolated from the more genetically heterogeneous I. scapularis 
population in the South. Similar studies were also conducted with I. pacificus, with 
significant genetic difference identified between I. pacificus and either population of I. 
scapularis; in addition, the F1 progeny of crossbreeding experiments between I. 
scapularis and I. pacificus were sterile (Wesson et al., 1993; Oliver Jr et al., 1993). 
Therefore, at present, two distinct species are considered the main vectors for B. 
burgdorferi in the United States: I. pacificus on the West Coast and I. scapularis in the 
East.   
15 
 
 Two distinct clades of I. scapularis have been described: the northern, American 
Clade and the Southern Clade. These clades remain genetically and phenotypically 
somewhat different although they constitute a single species. Populations of I. scapularis 
have been identified throughout the eastern US using 16S mitochondrial rDNA 
sequences. Current understanding of these two clades suggests that a few ticks from the 
original population became isolated in the Northeast, perhaps due to massive 
deforestation and unregulated hunting, leading to a historic decline of I. scapularis and 
subsequent homogeny (Qiuet al., 2002; Hoen et al., 2009). Regardless, the northern 
colony became the American Clade and served as the expanding group into the upper 
midwestern US and Canada (Humphrey et al., 2010, Ogden et al., 2013). Most recently, 
the expansion of the American Clade farther southward into Virginia was documented 
suggesting an actively expanding population from the Northeast, which may increase the 
risk of transmission of B. burgdorferi in these newly colonized areas (Brinkerhoff et al., 
2014). The genetic differences between the clades become important in assessing the 
host-seeking behaviors of each population (described later) and the overall risk of 
transmission of B. burgdorferi to humans and animals.   
  
INFECTION WITH BORRELIA BURGDORFERI AND DISEASE 
MANIFESTATIONS 
 Lyme borreliosis (LB) caused by Borrelia burgdorferi is the most commonly 
diagnosed vector-borne infection in humans in the United States (Bacon et al., 2008). 
Infection is transmitted to the host through the bite of an infected tick (Hayes et al., 
1983). In humans, a classic bulls-eye target rash, termed an erythema migrans, appears at 
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the site of tick attachment within 7–14 days. While this rash is clinically recognized in 
approximately 70% of human patients, veterinary patients infected with B. burgdorferi 
are not known to develop the lesion (Nadelman, 2015; Marques, 2010). The early clinical 
signs seen in humans and dogs include fever, lethargy, myalgia, and arthralgia, which can 
progress to more severe disease when left untreated.  
If diagnosed in the acute phase, LB can be treated, but persistent damage may be 
caused by the migrating spirochetes, resulting in long-term damage that can be less 
responsive to antibiotics (Wormser et al., 2006). In disseminated infections, the 
spirochetes colonize a variety of tissues resulting in arthritis, carditis, or neurologic 
problems depending on location (Marques, 2010). In dogs, the most serious form of LB is 
a glomerulonephritis that results in a protein-losing nephropathy; this presentation is seen 
in <1% of dogs that test positive for antibodies to B. burgdorferi (Dambach et al., 1997; 
Littman, 2013). While the exact mechanism of B. burgdorferi-induced canine 
glomerulonephritis is not known, it is speculated to be related to antigen-antibody 
complex deposition in the glomerulus rather than tissue invasion of the spirochete 
(Hutton et al., 2008; Littman, 2013).   
Of the other Borrelia spp. that make up the B. burgdorferi s.l. complex in the US, 
only B. bissettii and B. kurtenbachii are confirmed to be pathogenic to humans (Rudenko 
et al., 2011; Clark et al., 2014; Margos et al., 2010). Within the relapsing fever group, B. 
miyamotoi is the most recognized to cause disease in humans (Krause, et al., 2014). 
Infection with B. miyamotoi leads to similar presenting signs as classic LB including 
unexplained fever, headache and myalgia with or without skin rash (Lee et al., 2014). 
These non-specific signs in combination with the fact that B. miyamotoi is transmitted by 
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I. scapularis in Lyme disease-endemic areas make distinguishing the two infections 
difficult. A related spirochete, B. lonestari, has been implicated in relapsing fever-like 
disease manifestations in the South, but definitive proof of human infection has yet to be 
confirmed (Stromdahl et al., 2003). The wide variety of Borrelia spp. found worldwide 
and the non-specific disease manifestations induced in many patients make LB a 
challenging diagnosis for physicians, even in endemic areas. 
Treatment 
Like many tick-borne pathogens, B. burgdorferi can be readily treated with 
antibiotics if treatment is initiated promptly. For both humans and dogs, the antibiotic of 
choice is doxycycline. In humans, the most commonly recommended dosage is 100mg 
orally, twice a day for 10 days, but many doctors recommend a 14, 21, or 28-day course 
of antibiotics to prevent any long-term infections (Sanchez et al., 2016; Sanchez, 2015). 
Other effective antibiotics include amoxicillin (500mg; 3x/day; 14 days), and cefuroxime 
axetil (500mg; 2x/day; 14–21 days) is used for patients unable to tolerate beta-lactam or 
tetracycline class drugs (Sanchez et al., 2016; Little et al., 2010).  In dogs, most 
veterinarians reserve treatment for patients exhibiting clinical signs of LB. The drugs of 
choice in dogs are similar to humans, but the doses are scaled to patient size. 
Doxycycline at 10mg/kg twice per day or amoxicillin at 20mg/kg thrice per day for 30 
days are the most common treatment recommendations (Little et al., 2010; Krupka et al, 
2010). If the patient does not tolerate tetracycline or beta-lactam antibiotics, azithromycin 
at 25mg/kg once per day for 14 days can also be effective (Krupka et al., 2010). Patients 
exhibiting lameness or arthritic disorders may benefit from nonsteroidal anti-
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inflammatory drugs, but glucocorticoids should only be given in low doses that are not 
immunosuppressive.  
 
DIAGNOSIS OF LYME BORRELIOSIS 
Humans 
 Because symptoms of early infection are largely non-specific and flu-like, 
confirming a diagnosis of Lyme borreliosis (LB) may take several weeks to months. In 
endemic areas, the erythema migrans (EM) is considered to be diagnostic and an 
indication for treatment. Other available diagnostic tests include serology, polymerase 
chain reaction (PCR) for detection of DNA from B. burgdorferi within the infected 
tissues, and culture of the spirochetes from infected tissues (Nowakowski et al., 2001). A 
two tier serologic approach is currently recommended and consists of a sensitive enzyme 
immunoassay (EIA) followed by immunoblotting of samples that are positive or 
indeterminate in the first step (Sanchez et al., 2016). A PCR assay can be performed on 
any tissue samples, but EM or synovial fluid samples provide the most sensitive results. 
However, a negative PCR result does not rule out infection (Borchers et al., 2015). 
Culture of Borrelia sp. from tissues, including synovial fluid, EM, and cerebrospinal 
fluid, can also be attempted, but is often unrewarding (Nowakowski et al., 2001). 
Veterinary Species 
 Diagnosis of LB in veterinary patients is predominantly limited to serology 
because EM is not a common finding, PCR is largely unrewarding, and culture for B. 
burgdorferi is rarely performed other than in research laboratories. Two commonly used 
serologic tests for detection of antibodies in dogs include the SNAP 4Dx Plus Test kit 
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(IDEXX Laboratories, Westbrook, ME) and the AccuPlexTM4 (ANTECH Diagnostics, 
Irvine, CA); other diagnostic labs offer similar tests. In dogs and horses, a multiplex 
assay similar to the AccuPlexTM4 test is also used in attempt to identify early or late 
infection by detecting antibodies to three separate outer surface proteins, OspA, OspC, 
and OspF (Cornell University College of Veterinary Medicine Animal Health Diagnostic 
Center, Ithaca, NY). The SNAP 4Dx Plus Test kit detects antibodies to a single 
specific antigen, the C6 peptide based on the VlsE lipoprotein of B. burgdorferi, while 
the AccuPlexTM4 test detects antibodies to multiple antigens that are expressed in early 
infection, late infection, or after vaccination for B. burgdorferi (Levy, 2002; Stillman et 
al., 2014; Moroff et al., 2015). Follow-up quantitative tests are also available to confirm 
diagnosis in these patients.  
Limitations 
 There are limitations with the diagnostic routes taken in both humans and 
veterinary patients. In humans, the most common limitation is a delay in diagnosis, as 
many of the early, presenting signs are non-specific, especially in those patients that do 
not present with an EM or tick attachment is not seen (Marques, 2010). The second 
limitation is the highly cross-reactive nature of serologic tests for Borrelia spp., which is 
not limited to the B. burgdorferi sensu lato complex, but may also be cross-reactive with 
relapsing fever Borrelia spp. (Lane et al., 1990). Since many of these borreliae have 
unknown pathogenicity, these positive results may confound or delay the real diagnosis. 
There is also significant variance between commercial assays and even between medical 
laboratories, with 55% of reference laboratories failing to confirm previously seropositive 
patient samples (Theel, 2016).    
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Common canine diagnostic platforms have limitations as well. While rising titers 
can suggest active infection, a positive result on a serologic test, such as the SNAP 
4Dx Plus Test, does not necessarily indicate a current infection with B. burgdorferi. 
Since antibodies to B. burgdorferi have been shown to persist in the host for 1–3 years 
after effective treatment, a positive result indicates either current or previous infection 
and can only be accurately interpreted in light of the clinical signs (Krupka et al., 2010). 
There is considerable debate between the two corporate, canine serologic tests in regards 
to vaccination history. While the SNAP 4Dx Plus Test does not react with antibodies 
produced due to vaccination, the AccuPlexTM4 test reportedly does, although all 
vaccinated dogs do not test positive on this assay (Levy, 2002). Each approach may have 
benefits and limitations, and the results should only be interpreted with vaccination 
history and clinical signs in mind.  
Further diagnostic methods, such as PCR and culture, can provide definitive 
diagnosis that B. burgdorferi s.s. is present in the tissues, but a negative test result does 
not rule out LB as only small portions of tissues are used for testing and the spirochetes 
migrate throughout infection (Marques, 2010).  
 
MAINTENANCE OF LYME BORRELIOSIS IN NATURE 
Ticks 
 Maintenance of B. burgdorferi in nature is affected by many factors including the 
presence of reservoir hosts, habitat suitability, and climate; key characteristics that 
support the principal vector in eastern North America, I. scapularis. Larval I. scapularis 
emerge from the egg uninfected and acquire B. burgdorferi from infected reservoir hosts, 
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then maintain the infection transtadially with each molt (Patrican, 1997; Barbour and 
Fish, 1993).  The larval and nymphal stages are responsible for maintaining the enzootic 
cycle of B. burgdorferi. For the system to continue within the two-year life cycle of the 
tick, the larvae must feed after infected nymphs have fed on a reservoir host (Kurtenbach 
et al., 2006). The timing of these feedings is key to maintaining the bacteria within the 
reservoirs and is discussed in further detail within the “Climate” section. This phenologic 
timing is driven primarily by climate, and, together with host preferences and questing 
behavior, likely plays a role in the inability of I. scapularis to maintain B. burgdorferi 
effectively in the South (Oliver, 1996).  
Besides the climatic and environmental differences between the Northeast and the 
South, there are genetic differences between two distinct populations of ticks in these 
areas that have been described in the “Ixodes spp. of North America” section. Oliver et al. 
showed these two populations, previously I. dammini in the North and I. scapularis in the 
South, are in fact one species now termed I. scapularis, but still fall into two separate 
clades, the northern, American clade and the Southern clade (Oliver et al., 1993; Norris et 
al., 1996). These two clades appear to differ in host-seeking behavior, feeding 
preferences, and duration of attachment to different hosts, yet both are documented to be 
competent vectors of B. burgdorferi (Oliver et al., 1993; Goddard 1992). These 
differences in behavior directly impact the maintenance of B. burgdorferi in vertebrate 
reservoirs and the risk of exposure to humans and dogs. First, questing habits are 
significantly different between northern and southern I. scapularis, as indicated by the 
ability of researchers to flag/drag the nymphal ticks in nature. This common practice is 
used to estimate nymphal density and is effective at collecting significant numbers of I. 
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scapularis nymphs in the Northeast but does not provide large numbers of questing 
nymphs in the South, despite the nymphs being found on vertebrates commonly (Diuk-
Wasser et al., 2006). Immature I. scapularis also use different vertebrate reservoirs for 
their primary feeding, which in turn alter the ability to maintain B. burgdorferi in the 
wild. In the Northeast, immature I. scapularis feed largely on rodents and other small 
mammals, whereas in the South reptiles and birds fill this role more commonly (Arsnoe 
et al., 2015; Kollars et al., 1999). Finally, nymphal ticks are thought to be the major 
vector implicated in the majority of cases of Lyme borreliosis (LB) within the Northeast, 
but are not reported to be a major tick parasitizing humans in the South, perhaps due to 
questing habits in the region (Arsnoe et al., 2015). Overall, the phenology and host-
seeking behaviors of the Southern Clade I. scapularis perpetuates an inefficient 
maintenance cycle that prevents LB from becoming endemic in the South.  
Similarly, the primary vector for B. burgdorferi on the West Coast, I. pacificus, 
has different feeding patterns than that of northern I. scapularis, commonly feeding on 
small lizards (Lane, et al,. 1998; Eisen, et al., 2004). While I. pacificus is the vector 
considered to be primarily responsible for transmission of the bacteria to humans and 
dogs, some have suggested I. spinipalpis plays a role in maintaining the bacteria in 
reservoir rodents (Brown et al., 2006). This transmission cycle needs to be revisited as 
early infection and maintenance studies were performed using monoclonal antibodies that 
have since been shown to be cross-reactive with other Borrelia spp. (Shoberg et al., 1993; 
Bretz et al., 2000). The feeding habits of I. pacificus do appear to be key in limiting the 
expansion of the endemic area on the West Coast and minimizing the risk of infection to 
humans. The reliance on a vector for transmission and maintenance makes the tick a key 
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component to the expansion of the areas where LB is endemic as well as the risk of 
infection in endemic areas.    
 
Reservoir Hosts 
 Animal hosts are required for maintenance of both the ticks and the spirochetes in 
nature, but the type, density, and diversity of animals in a region can significantly affect 
the prevalence of B. burgdorferi in a population of ticks and thus change the risk of LB in 
that region. American Clade Ixodes scapularis larvae and nymphs feed predominantly on 
rodents and other small mammals, but are generalists that will opportunistically feed on a 
wide variety of animals such as reptiles and larger mammals, including humans (Brunner 
et al., 2008). The major reproductive host for the adult tick is the white-tailed deer, 
Odocoileus virginianus, but again the adults can be found on a wide variety of hosts, 
especially if deer populations are significantly altered (Lane et al., 1991; Kilpatrick et al., 
2014). Historically, the principal reservoir host for B. burgdorferi was thought to be the 
white-footed mouse, Peromyscus leucopus, but more recent research has shown other 
hosts could be more important. Although >85% of ticks fed on infected white-footed 
mice will acquire the pathogen, only 10% of the immature ticks collected from wildlife 
are from this host (Brisson et al., 2008). Both reservoir competency and tick carrying 
capacity ultimately determine if an animal is a suitable reservoir. When tick carrying 
capacity is considered, some estimates suggest P. leucopus is likely responsible for only 
25% of the infected nymphal ticks in a particular region (Brisson et al., 2008; Ogden and 
Tsao, 2009). Other important vertebrate reservoirs include the masked shrew (Sorex 
cinereus), short-tailed shrew (Blarina brevicauda), eastern chipmunk (Tamias striatus), 
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and gray squirrel (Sciurus carolinensis). These 4 reservoirs all have a reservoir 
competence greater than 15% and serve as a more likely host for the immature ticks, 
which in turn allows them to infect more ticks (Brisson et al., 2004; Brisson et al., 2008). 
Other low competence reservoirs include the raccoon (Procyon lotor), Virginia opossum 
(Didelphis virginiana), striped skunk (Mephitis mephitis), white-tailed deer (Odocoileus 
virginianus), and various bird species, which can serve as a host to large numbers of 
immature ticks but are very poor at infecting naïve ticks, and therefore are not considered 
important reservoirs (LoGuidice et al., 2008).  Small mammal reservoirs appear to infect 
a larger percent of ticks with higher spirochete numbers, and therefore those hosts with 
the most ticks constitute the primary reservoirs for the bacteria in the wild (Barbour et al., 
2015).  
   Although in a healthy, diverse habitat, the white-footed mouse may only play a 
minor role in maintaining B. burgdorferi, in disturbed habitats this host becomes much 
more important. In areas where less competent reservoir hosts actively compete with P. 
leucopus or a large portion of ticks do not feed on P. leucopus, vertebrate host 
biodiversity appears to decrease the prevalence of bacteria in the feeding ticks.  In 
contrast, with a stable white-footed mouse population, increasing the number of animals 
on which ticks can feed may ultimately increase the number of ticks infected thus 
increasing the risk of LB in that area (Brisson et al., 2008; Bouchard et al., 2013; Ogden 
and Tsao 2009). In the southern US and along the West Coast, larval and nymphal ticks 
commonly feed on lizards, a preference commonly thought to play a role in the dearth of 
the disease in these areas (Durden et al., 2002; Lane et al., 1998).  Because of the 
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generalist behavior of I. scapularis, controlling a single reservoir is considered to be 
unlikely to reduce pathogen prevalence in ticks.  
Birds also play a key role in maintaining populations of I. scapularis as well as 
providing a route by which the ticks can move large distances. Birds often serve as a host 
for immature ticks, including I. scapularis. While the immature ticks readily feed on 
birds in general, no bird species has been shown to be a particularly efficient reservoir for 
B. burgdorferi, with a reservoir competence around 10% (Brisson et al., 2008). The major 
impact bird hosts have is in the dispersal of ticks throughout migration routes. This 
migration of ticks on birds leads to the collection of a few, adventitious ticks of varying 
life stages in unexpected locations, but over time these small populations can become 
established. Migratory birds have been shown to aid in the expansion of the range of I. 
scapularis in both the midwestern United States and Canada (Schneider et al., 2015; 
Ogden et al., 2008). Currently, the role of birds in expansion is much clearer in Canada, 
as populations of I. scapularis throughout the country are geographically isolated from 
one another (Ogden et al., 2008). Due to the continuous migration of birds, adventitious 
ticks are found routinely. The Canadian Consensus Conference on Lyme Disease 
considers an area endemic only when all three feeding stages of the tick are found on an 
animal or in the environment for at least 2 consecutive years (Laboratory Centre for 
Disease control, 1991).  
Habitat 
 Because B. burgdorferi spends no time outside of either a reservoir host or vector, 
environmental conditions favoring the maintenance of the bacteria in nature are focused 
on those conditions that support tick and host populations. Soil type is one key factor for 
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tick survival as the ticks over-winter in the topsoil. The extremes of very sandy soil and 
hard clay are both poor habitats for tick survival since they do not hold enough water or 
hold too much water, respectively (Guerra et al., 2002). The presence of dry or wet, silty 
loam has been shown to support significant populations of I. scapularis (Glass et al., 
1994; Ogden,et al., 2006). This soil type can also support a healthy forest habitat, which 
is similarly important to tick survival (Guerra et al., 2002). In general, an increase in 
normalized difference vegetative index (NDVI), the density of green on a patch of land, 
correlates with an increase in I. scapularis density, but some specific forest types allow 
for better tick survival than others (Ogden et al., 2006).  Deciduous forest, supported by 
oak or maple trees, have been shown to be best for supporting populations of I. 
scapularis as the leaf litter provides refuge for the ticks from the elements (Guerra et al., 
2002; Ogden et al., 2006). In contrast, forested areas that consist mainly coniferous, 
evergreen trees do not provide an ideal habitat for ticks (Guerra et al., 2002). The risk for 
LB in a given area can be associated with subtle changes in the structure of the forested 
area. The risk for LB is highest when the suitable habitats interface with human or canine 
contact, which are most likely to be forest edge habitats such as trails (Brownstein et al., 
2005). Fragmentation not only creates more areas of possible exposure, but also supports 
the increase of pathogen prevalence in ticks, presumably by removing some of the larger 
dilutional reservoir hosts while not affecting the white-footed mouse populations, a 
change that would provide a bias towards immature ticks feeding on an efficient reservoir 
(Allan et al., 2003). Vegetation, soil, and climate are interconnected, and extremes of any 
factor may affect the ability of ticks to survive in nature, ultimately affecting the risk of 
LB in that area.  
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Climate 
 While macroclimatic variables dictate the overall distribution of LB, 
microclimatic variables within each specific region can also affect tick survival and 
pathogen prevalence, significantly altering the maintenance of the pathogen in nature. 
Temperature is the main macroclimatic variable that affects tick development for each 
stage, such that each development phase is shorter as temperature increases, despite the 
fact that the range for LB is generally confined to lower average temperature areas in the 
northeastern and upper midwestern parts of the US (Ogden et al., 2004). Questing activity 
is also affected by temperature. Adults quest most actively between 5–15°C, whereas 
nymphs become more active at 15°C, peaking at 25°C, and declining as temperature 
increases further (Ogden et al., 2004). Overall survival rates at different temperatures 
have also been examined, with both northern and southern populations of I. scapularis 
surviving longer under conditions that simulate the climate of the Northeast (Ginsberg et 
al., 2014).  These climatic results are thought to be the basis for southern populations of I. 
scapularis questing in nature below the cover of leaf litter. A recent, overall increase in 
temperature correlates with an expanding population of infected I. scapularis in Canada 
(Ogden et al., 2014). On the other hand, there also appears to be expansion of the 
American Clade I. scapularis southward. Ixodes scapularis collected from southwest 
Virginia were both novel to the area and found at altitudes that were higher than expected 
(Brinkerhoff et al., 2014). This increase in altitude may allow the expansion of this tick 
population into areas that are warmer than the traditional endemic range for LB.  
Changes in temperature also affect the seasonality of feeding for each of the life 
stages, which in turn can alter the pathogen prevalence and maintenance within the ticks. 
28 
 
Because spirochaetemia is short-lived in rodents, usually lasting less than two weeks, it is 
important that naïve larval stages of I. scapularis feed within a short period after the 
infected nymphal stages feed (Hovius et al., 2007). When infected nymphal ticks feed in 
spring followed by emergence and feeding of uninfected larvae in the summer, 
transmission and maintenance of B. burgdorferi in the population is most efficient 
(Ogden et al., 2004; Gatewood et al., 2009).  On the other hand, when nymphal I. 
scapularis feed in the fall and the larvae do not feed until the following spring/summer, 
transmission is inefficient (Ogden et al., 2004).  This latter cycle, which results in 
disruption of maintenance of infection due to an inverted phenology, has been observed 
in field studies conducted in the southeastern US where pathogen prevalence in ticks and 
LB incidence in humans and dogs is much lower than that of the Northeast, which has the 
spring nymphs/summer larvae feeding cycle (Oliver, 1996).  
Microclimate within the forest is also important for tick survival and includes air 
temperature, soil temperature, and relative humidity. The leaf litter provided by a thriving 
deciduous forest can provide a more stable environment for these variables (Guerra et al., 
2002). Increased tick survival has been associated with higher relative humidity, whereas 
a higher air temperature, soil temperature, and low humidity are associated with 
decreased survival (Bertrand and Wilson, 1996). Environments with stable temperatures 
are considered optimal (Bertrand and Wilson, 1996). Interplay between the vector, 
reservoirs, habitat, climate, and pathogen form a complex web necessary for maintenance 
of the pathogen in nature and, ultimately, transmission to people and dogs.  
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PREVALENCE 
 The prevalence of Borrelia burgdorferi infection in dogs, people, horses, ticks 
and other animals has been established in different regions of the US and Canada. The 
prevalence is determined by interpreting one or more of the previously discussed 
diagnostic methods for a specific host.  
Dogs 
 Two large serosurveys of pet dogs were reported using data from 2001–2007 and 
2010–2012, respectively; all samples were tested with patient-side ELISAs (SNAP® 
3Dx®, 4Dx®, and 4Dx® Plus; IDEXX Laboratories, Inc., Westbrook, Maine) designed 
to detect antibodies to B. burgdorferi sensu stricto (Bowman et al., 2009; Little et al., 
2014). In both studies, the Northeast region had the highest reported prevalence, 11.6% 
and 13.3%, respectively (Table 1). The regional B. burgdorferi antibody prevalence for 
the Midwest, Southeast, and West were 4.0–4.4%, 1.0%–2.5%, and 1.4% (both studies) 
(Table 1). The state with the highest prevalence in the earlier study was Connecticut 
(18.1%; 1,846/10,209) while Massachusetts had the highest prevalence of antibodies to 
B. burgdorferi in the follow-up study (18.3%; 74,429/406,493) (Bowman et al., 2009; 
Little et al., 2014). Another nationwide study of 6,582 dogs was conducted utilizing a 
novel species-specific peptide assay (SNAP® M-A, IDEXX Laboratories, Inc., 
Westbrook, ME). While the prevalence differed from previous studies, the Northeast 
remained the focus for the majority of antibody positive test results with 22.9% (122/532) 
of samples testing positive (Table 1) (Qurollo et al., 2014).   
 Local or regional serosurveys for antibody to Borrelia spp. in dogs have also been 
reported (Table 1). States with local data on antibody presence in dogs include Alabama, 
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California, Connecticut, Florida, Illinois,, Maine, Maryland, Massachusetts, Michigan, 
Minnesota, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, 
Oregon, Pennsylvania, Rhode Island, Virginia, Washington, Wisconsin (Wright et al., 
1997; Carrade et al., 2011; Magnarelli et al., 1987; Tzipory et al., 2010; Rand et al., 2011; 
Rand et al., 1991; Eschner et al., 2015; Duncan et al., 2005; Daniels et al., 1993; Greene 
et al., 1991; Lindenmayer et al., 1991; Hamer et al., 2009; Beall et al., 2008; Gaito et al., 
2014; Schulze et al., 1987; Falco et al., 1993; Magnarelli et al., 1990; Greene et al., 1988; 
Wang et al., 2014; Mukolwe et al., 1992; Rodgers et al., 1989; Hinrichsen et al., 2001). 
Two local studies utilizing PCR to detect circulating spirochetes in whole blood of dogs 
have also been reported (Table 1) (Fryxell et al., 2012; Wagner et al., 2012). 
 Similar large scale and regional studies have been carried out in Canada and 
document canine infection with B. burgdorferi in every province, although some 
positives are thought to represent translocation of dogs from endemic areas. Provinces 
with the highest prevalence in each of the two national studies reported to date are Nova 
Scotia, Ontario, and Prince Edward Island (Table 2) (Ourollo et al., 2014; Villeneuve et 
al., 2011). Additional regional surveys have been conducted in British Columbia, Nova 
Scotia, Ontario, Prince Edward Island, Quebec, and Saskatchewan (Table 2) (Bryan et al., 
2011; Banerjee et al., 1996; Bell et al., 1992; Gary et al., 2006; Artsob et al., 1993; 
Artsob et al., 1992; Schurer et al., 2014). 
Humans 
 Lyme borreliosis has been a nationally notifiable disease in humans in the US 
since 1991 through the Center for Disease Control’s National Notifiable Diseases 
Surveillance System (NNDSS). The disease is the most commonly reported vector-borne 
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infection in the United States and the fifth most common nationally notifiable disease 
(CDC, 2015). Despite being a commonly reported disease, LB is still only considered 
regionally endemic and 95% of all cases come from 14 states in the Northeast and Upper 
Midwest (CT, DE, ME, MD, MA, MN, NH, NJ, NY, PA, RI, VT, VA, WI) (CDC, 2015; 
Bacon et al., 2008). There are roughly 25,000–30,000 new cases each year nationwide, 
but the CDC estimates the actual number of new cases each year is closer to 300,000 due 
to under-reporting (CDC, 2013). The actual incidence of LB is 7.0–10.0 cases per 
100,000 people nationally each year, but the incidence in endemic areas, such as 
Connecticut, Maine, New Hampshire, and Vermont, can range from 50.0–110.0 cases per 
100,000 people (CDC, 2015). Outside of these hyperendemic ranges the typical incidence 
each year is less than 1.0 case per 100,000 in the South and West Coast.  
 The Public Health Agency of Canada first listed LB as a reportable disease in 
2009. Since that time, the number of reported cases has increased from 144 in 2009 to 
682 in 2013 (PHAC, 2102; PHAC 2013). The overall incidence of LB in Canada is 1.9 
cases per 100,000 people, but again there are large variances depending on the region 
(PHAC, 2013). For instance, Nova Scotia has the highest incidence with 16.9 
cases/100,000, while Alberta and Newfoundland & Labrador have no documented cases 
of local infection; all were associated with travel (PHAC, 2013). Even within the large 
provinces where the disease is considered endemic, the incidence may be misleading. 
Ontario and Quebec have an incidence of 2.4 cases/100,000 and 1.7 cases/100,000, yet 
the majority of those cases cluster in the southern Great Lakes region and near the 
US/Canada border (PHAC, 2012; PHAC, 2013).  
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Horses 
 Although joint, ocular, dermatologic, and neurologic manifestations have been 
reported in horses, comprehensive surveys of the entire United States or Canada are not 
available (Preist et al., 2012; Sears et al., 2012; James et al., 2010). The majority of 
studies are on horses that have already been deemed “Lyme suspect” by a veterinarian, 
which skews the data towards a higher prevalence (Burbelo et al., 2011; Magnarelli and 
Fikrig, 2005). Equine serosurveys in endemic regions for LB in the US and Canada 
where clinically normal horses have been tested for antibodies to B. burgdorferi 
document antibody prevalence of 8.0% (168/2100)–45.1% (37/82) (Bernard et al., 1990; 
Schvartz et al., 2015; Magnarelli et al., 2000; and Wagner et al., 2012). Recently, a 
random selection of horses in southwest Virginia were screened for antibodies to B. 
burgdorferi using the Lyme Accuplex Assay. Thirty-three percent (83/250) of horses 
tested positive for at least one outer surface protein (Osp), and of the horses that tested 
positive and were available for follow-up, 63% (40/63) remained positive for 5–17 
months after the initial exam (Funk et al., 2016).  
Cats 
 Although cats experimentally infected with B. burgdorferi developed an antibody 
response and displayed a variety of clinical signs, there have been no documented reports 
of clinical disease in a naturally infected cat (Gibson et al., 1995; Krupka et al., 2010). 
The serologic studies in cats are few and are limited to Lyme disease-endemic regions of 
the northeastern United States. The prevalence of antibodies to B. burgdorferi in healthy 
cats ranges from 14.0% (10/71) – 46.4% (39/84), while clinically ill or those infested 
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with ticks had a higher prevalence of antibody from 55.6% (5/9) – 70.8% (17/24) 
(Magnarelli et al., 2005; Magnarelli et al., 1990; Levy et al., 2003).  
Ticks 
 Ticks have been evaluated by active or passive surveillance for the presence of B. 
burgdorferi sensu stricto (Table 4). In the last decade alone, surveys document B. 
burgdorferi in I. scapularis from Alabama, Arkansas, Connecticut, Georgia, Illinois, 
Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland Massachusetts, Michigan, 
Minnesota, Mississippi, Missouri, New Hampshire, New Jersey, New York, North 
Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, 
Tennessee, Texas, Utah, Vermont, Virginia, and Wisconsin (Table 3) (Diuk-Wasser et 
al., 2012; Fyxell et al., 2012; Feldman et al., 2015; Diuk-Wasser et al., 2014; Crowder et 
al., 2010; Hanincová et al., 2006; Rydzewski et al., 2011; Gatewood et al., 2009; Jobe et 
al., 2007; Jobe et al., 2006; Steiner et al., 2008; Lingren et al., 2005; Taft et al., 2005; 
Leydet Jr et al., 2014; Leydet Jr et al., 2013; MacQeen et al., 2012; Swanson et al., 2007; 
Giery et al., 2007; Anderson et al., 2006; Hamer et al., 2012; Hamer et al., 2010; Hamer 
et al., 2009; Stromdahl et al., 2014; Goltz et al., 2013; Walk et al., 2009; Schulze et al., 
2013; Dolan et al., 2011; Schulze et al., 2006; Ullmann et al., 2005; Schulze et al., 2005; 
Hersh et al., 2014; Aliota et al., 2014; Prusinski et al., 2014; Tokarz et al., 2010; Moreno 
et al., 2005; Maggi et al., 2010; Russart et al., 2014; Wang et al., 2014; Hutchinson et al., 
2015; Brown et al., 2015; Han et al., 2014; Connally et al., 2006; Mays et al., 2014; 
Rosen et al., 2012; Feria-Arroyo et al., 2014; Davis et al., 2015; Herrin et al., 2014; 
Brinkerhoff et al., 2014; Turtinen et al., 2015; Lee et al., 2014). In areas where B. 
burgdorferi is endemic or hyperendemic, prevalence of infection in nymphal and adult I. 
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scapularis typically ranges between 15% and 50% (Diuk-Wasser et al., 2012; Crowder et 
al., 2010; Gatewood et al., 2009; Steiner et al., 2008). Borrelia burgdorferi has also been 
reported in I. pacificus in California and Oregon (Table 3) (Padgett et al., 2014; Lane et 
al., 2010; Swei et al., 2011; Eisen et al., 2010; Crowder et al., 2010; Salkeld et al., 2014; 
Lane et al., 2013; Holden et al., 2006; Doggett et al., 2008).  
 In Canada, a large scale passive surveillance study of I. scapularis found the 
presence of B. burgdorferi in ticks in every province evaluated except British Columbia 
and Saskatchewan (Table 4) (Ogden et al., 2006). Since then, other regional studies using 
active collection of ticks have confirmed these results in the same provinces (Table 4) 
(Dibernardo et al., 2014; Gabriele-Rivet et al., 2015; Scott et al., 2016; Nelder et al., 
2014; Scott et al., 2008; Morshed et al., 2006; Bouchard et al., 2013; Ogden et al., 2010).  
 
EXPANDING DISTRIBUTION OF  
BORRELIA BURGDORFERI SENSU STRICTO 
Northeast Focus Expanding Southward 
 Although the principal reservoir host, Peromyscus leucopus, and primary vector, 
I. scapularis, are distributed throughout North America and most of the eastern US 
respectively, in the United States, laboratory-confirmed reports of LB are generally 
confined to states in the Northeast, mid-Atlantic, and upper Midwest (Duik-Wasser et al., 
2012). Infection with B. burgdorferi is most common in the Northeast, with the 14 most 
northeastern states reporting 95% of all human LB cases in the US (Nelson et al., 2015). 
Prevalence of exposure in dogs parallels that in humans, with the majority of dogs with 
detectable antibodies to B. burgdorferi identified in the Northeast (Bowman et al., 2009; 
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Little et al., 2014). Historically, the southern border of this region was considered to be 
coastal Maryland and northern coastal Virginia (Wormser et al., 2006). Indeed, until 
2011, questing I. scapularis had not been reported inland towards the mountainous, 
southwestern regions of Virginia (Sonenshine et al., 1995; Amerasinghe et al., 1992; 
Oliver, 1988; Brinkerhoff et al., 2014). Models to predict the expansion of the endemic 
area southward initially predicted the expansion to occur along the mid-Atlantic coast, 
sparing the higher elevations of the Appalachian Mountains (Duik-Wasser et al., 2006; 
Duik-Wasser et al., 2012). However, recent field collections have shown an increase in B. 
burgdorferi-infected I. scapularis, human case reports of LB, and antibodies to B. 
burgdorferi in dogs in the higher elevations of southwestern Virginia (Brinkerhoff et al., 
2014). The reason for the expansion of infected tick vectors into the higher elevations is 
currently unknown, but climate change allowing more favorable environmental 
conditions at such elevations is considered key to this phenomenon (Brinkerhoff et al., 
2014).  
Midwest Focus Expanding Outward 
 One of the major focal endemic areas for LB is the Upper Midwest of the United 
States, including Wisconsin, Minnesota, northern Illinois, and western Michigan. 
Interestingly, this population of ticks remains genetically distinct from those in the 
northeastern endemic range (Margos et al., 2012). Lyme borreliosis (LB) was first 
diagnosed in humans in the 1980’s in a fairly circumscribed area of Wisconsin and 
western Michigan (Dryer et al., 1979; Godsey et al., 1987). In the early 1990’s, annual 
case reports from the Centers for Disease Control and Prevention (CDC) identified the 
majority of cases in a focal area around eastern Minnesota and western Wisconsin 
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(Centers for Disease Control, 1991). Since that time, the area of documented endemicity 
has expanded in all directions. (Walker et al., 1998; Guerra et al., 2001; Hamer et al., 
2009).  
 Starting with passive surveillance collections for I. scapularis in 1986, the Ohio 
Department of Natural Resources (ODNR) reported an average of 1.75 ticks per year 
from 1989 to 2008, followed by a sharp increase in numbers to 182 ticks collected in 
2012 (Wang et al., 2014). This increase in ticks also correlated with an increase in 
infected ticks and seroprevalence in dogs and humans (Wang et al., 2014; CDC, 2015). 
Now that all three life stages of the tick, >5% prevalence in ticks, and 11.5% 
seroprevalence in dogs has been documented, Ohio can be considered a newly endemic 
area for LB, and it appears the northeastern and midwestern endemic regions of the 
United States will soon converge (Wang et al., 2014; Little et al., 2014).  
The area of endemicity is also expanding westward. In a recent survey of ticks in 
North Dakota, adults and immature stages of I. scapularis were found in 6 northeastern 
counties, and 6% of the questing adults were positive for B. burgdorferi by PCR (Russart 
et al., 2014). This new finding is mirrored by data from southern Canada, reporting 
increased numbers of I. scapularis in southeastern Manitoba expanding westward (Ogden 
et al., 2010). As the environment, reservoir hosts, and climate continues to change, the 
Midwest range of LB is expected to expand further to suitable, forested habitats nearby 
(Wang et al., 2014).    
West Coast 
 Lyme borreliosis on the West Coast has a distinct maintenance cycle compared to 
the eastern US. The differences affect both geographic distribution of the tick vectors and 
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transmission dynamics between reservoir hosts and to people and dogs. In this region, B. 
burgdorferi is transmitted to people and dogs by I. pacificus and the major reservoir is the 
dusky-footed woodrat (Neotoma fuscipes) (Brown et al., 1992). While I. pacificus is 
considered to be the main vector for the bacteria to humans, other tick species including 
I. spinipalpis and I. jellisoni may serve as the reservoirs maintaining the bacteria in nature 
(Eisen et al., 2003). Historically, this system has been considered to be the normal cycle, 
with I. pacificus primarily serving as a bridge vector since it is much less likely to feed on 
rodents (Lane et al., 1991; Lane et al., 1994).  Ixodes pacificus commonly feed on reptiles 
such as the western fence lizard (Sceloporus occidentalis) and the southern alligator 
lizard (Elgaria multicarinata), which do not serve as highly competent reservoirs for B. 
burgdorferi and have borreliacidal factors within their blood that further decrease the 
likelihood of transmitting the bacteria (Brown et al., 2006). Furthermore, the other Ixodes 
spp. thought to be maintaining the sylvatic cycle of transmission are not known to feed on 
humans or dogs. 
The areas where LB is endemic on the West Coast include the northern coastal 
mountain ranges extending up into Washington and Oregon and the foothills of the Sierra 
Nevada (Foley et al., 2007). The southernmost border of the area is the foothills of the 
Sierra Nevada near San Francisco, while the northern border extends into British 
Columbia, Canada (Foley et al., 2007). Unlike the endemic ranges for LB transmitted by 
I. scapularis in the US and Canada, which have expanded dramatically in recent years, 
the maintenance system in the West reliant on I. pacificus remains fairly stable. A lower 
prevalence of infection in ticks and a diverse and less competent reservoir population of 
animals likely limit opportunities for expansion to other suitable habitats along coastal 
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California (Clover et al., 1995; Eisen et al., 2004; Lane et al., 2005; Ogden et al., 2008). 
This situation is mirrored in southern British Columbia and suggests the distribution of 
LB on the West coast may remain relatively unchanged in the foreseeable future.  
Incursion into Canada 
 Lyme borreliosis has become a growing concern in Canada over the last decade. 
While I. scapularis have been found along the northern shore of Lake Erie since the early 
1970’s (Watson et al., 1976), populations of blacklegged ticks were not studied in Canada 
until the early 1990’s after B. burgdorferi was isolated from a tick in southern Ontario 
(Nelder et al., 2014). At this point, the National Microbiology Laboratory (NML) of the 
Public Health Agency of Canada (PHAC) and the Lyme Disease Association of Ontario 
started conducting passive surveys for I. scapularis, which yielded mainly ticks found 
attached to humans and pets (Ogden et al., 2006).  Since the testing began, B. burgdorferi 
infected I. scapularis have been collected from humans and dogs in every province east 
of Alberta. British Columbia also has B. burgdorferi infected-I. pacificus which have 
apparently expanded northward from the historic focus in the western US. Reports of I. 
pacificus in western Canada have been documented since the mid 1990’s but the endemic 
range of LB and number of cases does not appear to be increasing at the same pace as in 
the eastern provinces (Ogden et al., 2008). Accordingly, much of the current research has 
focused on the expansion of the range of I. scapularis and B. burgdorferi in southeastern 
Canada.   
Expansion within Canada 
 Currently, the areas of southeastern Canada with the largest population of I. 
scapularis harboring B. burgdorferi are along the northern shores of Lake Ontario, Lake 
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Erie, and the St. Lawrence River. These areas are directly adjacent to areas within the 
United States that are considered endemic for LB, and most researchers in the field have 
concluded that the ticks were originally introduced by migrating birds (Scott et al., 2001). 
While initially these populations constituted small groups of adventitious ticks deposited 
by birds, the habitat of southeastern Canada was apparently suitable for establishing 
endemic foci due to the relatively mild climate and ample woodland habitat (Ogden et al., 
2006; Barker and Lindsay 2000). These conditions have also allowed for the maintenance 
cycle for the agent of LB to expand throughout southeastern Canada, including Quebec, 
Ontario, New Brunswick, Nova Scotia, and southeastern Manitoba (Ogden 2006). More 
recent studies have documented that between 15% and 20% of adult ticks in these regions 
are infected with B. burgdorferi (Ogden et al., 2008; Ogden et al., 2014), which, while 
slightly lower than the infection prevalence in adult ticks in the northeastern endemic 
region of the United States, is similar to in the prevalence reported from tick vectors in 
the upper Midwest (Schultze, et al., 2005, Caporale et al., 2005).  
 Research documenting the patterns and processes responsible for expansion of 
endemic areas in Canada in the past decade has been used to generate predictive models 
for future distribution patterns. For large portions of southeastern Canada, the climate 
seems to be the limiting factor restricting distribution of both rodent reservoir hosts and 
tick vectors, and thus the maintenance cycle for the spirochetes. Climate change has the 
potential to rapidly increase the rate of expansion of the endemic LB range in Canada, 
shifting the primary limiting factor to habitat type. Current studies suggest, given the 
existing habitats and the continued trend of increasing temperatures, the high risk zone 
for LB in Quebec could move as much as 150 kilometers northward from its current 
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northern boundary (45° 0’ 0” N) at a rate of 3.5 kilometers per year (Simon et al., 2014). 
This trend would be expected to be seen throughout much of southeastern Canada and 
would likely also include a westward expansion similar to that seen in the northern US 
(Russart et al., 2014).      
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Table 1: Reported seroprevalence of antibodies to B. burgdorferi in dogs from the US 
State Prevalence (positive/tested) Reference 
Alabama 0.0% (0/40)A 
0.7% (367/53,340)A 
0.1% (27/18,998)A 
1.7% (10/579)B 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Wright et al., 1997 
Alaska   
Arizona 6.7% (1/15)A 
0.8% (424/55,893)A 
0.4% (4/992) A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Arkansas 0.0% (0/36)A 
0.5% (220/42,776)A 
4.0% (7/173)E  
0.1% (7/8,391)A 
Qurollo et al., 2014 
Little et al., 2014 
Fryxell et al., 2012 
Bowman et al., 2009 
California 2.5% (3/121)A 
1.6% (4,447/270,516)A 
2.0% (25/1255)A 
1.8% (540/29,454)A 
Qurollo et al., 2014 
Little et al., 2014 
Carrade et al., 2011 
Bowman et al., 2009 
Colorado 4.1% (10/246)A 
1.0% (192/19,489)A  
0.4% (49/11,557)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Connecticut 33.3% (16/48)A 
18.0% (33,071/183,787)A 
18.1%(1,846/10,209)A 
66.5% (103/155)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Magnarelli et al., 1987 
Delaware 25% (1/4)A 
9.5% (4,671/49,126)A 
11.2% (516/4,595)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
District of Columbia 26.7% (24/90)A 
8.2% (574/7,029)A  
Qurollo et al., 2014 
Little et al., 2014 
Florida 1.6% (8/501)A 
1.0% (3,832/403,886)A 
0.5% (5/1,000)A 
0.5% (256/54,982)A 
Qurollo et al., 2014 
Little et al., 2014 
Tzipory et al., 2010 
Bowman et al., 2009 
Georgia 3.7% (6/162)A 
0.8% (985/124,665)A  
0.3% (77/23,333)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Hawaii 0.3% (6/2,360)A  Little et al., 2014 
Idaho 3.6% (6/169)A  
0.3% (1/369)A 
Little et al., 2014 
Bowman et al., 2009 
Illinois 6.0% (23/383)A 
3.0% (8,413/277,352)A 
1.0% (324/31,976)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Indiana 9.7% (9/93)A 
3.5% (3,961/112,480)A  
Qurollo et al., 2014 
Little et al., 2014 
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1.1% (231/20,515)A Bowman et al., 2009 
Iowa 11.5% (9/78)A 
2.9% (3,236/111,522)A  
0.9% (149/17,390)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Kansas 0.0% (0/53)A 
0.5% (263/52,435)A  
0.1% (6/5,473)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Kentucky 5.8% (4/69)A 
1.5% (847/56,049)A  
0.2% (45/18,935)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Louisiana 0.0% (0/27)A 
0.4% (48/12,449)A  
0.1% (9/11,197)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Maine 
 
1.0% (46/4505)A 
27.6 (357/1294)A 
25% (1/4)A 
13.5% (29,860/221,556)A 
12.7% (138/1,087)A 
11.6% (3,269/28,230)A 
4.3% (36/828)C 
Eschner et al., 2015Vacc 
Eschner et al., 2015Non 
Qurollo et al., 2014 
Little et al., 2014 
Rand et al., 2011 
Bowman et al., 2009 
Rand et al., 1991 
Maryland  24.9% (78/313)A 
10.0% (27,348/273,406)A 
12.6% (2,882/22,945)A 
14.4% (24/167)A 
2.4% (119/494)C 
46.2% (43/93)BC 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Duncan et al., 2005 
Daniels et al., 1993 
Greene et al., 1991 
Massachusetts 40% (14/35)A 
18.3% (74,429/406,493)A 
19.8% (6,729/33,915)A 
1.4% (1/71)C 
20.3% (611/3011)C 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Daniels et al., 1993 
Lindenmayer et al., 1991 
Michigan 0.0% (0/20)A 
1.2% (2,936/236,875)A 
0.6% (431/67,625)A 
0.6% (2/353)D 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Hamer et al., 2009 
Minnesota 25.0% (2/8)A 
8.6% (20,159/234,564)A 
9.5% (7,267/76,610)A 
36.6% (268/731)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Beall et al., 2008 
Mississippi 0.0% (0/16)A 
0.7% (43/6,643)A 
0.0% (1/2,198)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Missouri 0.0% (0/36)A 
0.6% (616/108,580)A 
0.2% (59/24,095)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Montana 0 (0/37)A Little et al., 2014 
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Nebraska 0.0% (0/3)A 
2.0% (91/4,489)A 
0.1% (5/4,282)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Nevada 0.0% (0/5)A 
0.6% (74/12,286)A  
Qurollo et al., 2014 
Little et al., 2014 
New Hampshire 26.3% (5/19)A 
15.8% (20,447/129,842)A 
12.9% (2,343/18,122)A 
2.6% (4/151)C 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Daniels et al., 1993 
New Jersey 33.3% (4/12)A 
13.1% (38,695/295,084)A 
8.9% (18/202)A 
14.2% (2,913/20,575)A 
34.7% (147/423)B 
Qurollo et al., 2014 
Little et al., 2014 
Gaito et al., 2014 
Bowman et al., 2009 
Schulze et al., 1987 
New Mexico 1.6% (1/61)A 
0.7% (185/26,714)A  
0.3% (7/2,060)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
New York 17.1% (35/205)A 
9.5% (50,802/536,978)A 
23.1% (104/451)F 
7.1% (5,781/81,305)A 
49.2% (711/1446)C 
11.5% (10/87)C 
57.8% (242/419)C 
76.3% (87/114)BC 
Qurollo et al., 2014 
Little et al., 2014 
Wagner et al., 2012 
Bowman et al., 2009 
Falco et al., 1993 
Daniels et al., 1993 
Magnarelli et al., 1990 
Magnarelli et al., 1987 
North Carolina 5.4% (55/1,014)A 
1.9% (4,837/249,170)A 
1.3% (263/20,783)A 
0.4% (4/987)A 
3.4% (15/446)C 
1.8% (8/446)B 
3.3% (33/1002)B 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Duncan et al., 2005 
Greene et al., 1991 
Greene et al., 1991 
Greene et al., 1988 
North Dakota 5.4% (893/16,560)A  
3.0% (136/4,558)A 
Little et al., 2014 
Bowman et al., 2009 
Ohio 3.7% (16/430)A 
0.7% (1,970/278,493)A 
11.5% (41/355)C  
0.2% (140/61,138)A 
Qurollo et al., 2014 
Little et al., 2014 
Wang et al., 2014 
Bowman et al., 2009 
Oklahoma 0.0% (0/42)A 
0.6% (445/70,753)A 
0.2% (19/11,549)A 
11.7% (26/223)C 
18% (47/259)B 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Mukolwe et al., 1992 
Rodgers et al., 1989 
Oregon 0.0% (0/35)A 
1.7% (312/17,893)A 
0.15% (1/648)A 
Qurollo et al., 2014 
Little et al., 2014 
Carrade et al., 2011 
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2.8% (77/2,798)A Bowman et al., 2009 
Pennsylvania 22.2% (45/203)A 
12.9% (74,481/579,657)A 
9.4% (3,869/40,948)A 
25.0% (10/40)A 
1.2% (1/81)C 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Duncan et al., 2005 
Daniels et al., 1993 
Rhode Island 15.7% (10,001/63,797)A 
14.3% (933/6,508)A 
51.6% (143/277)C 
Little et al., 2014 
Bowman et al., 2009 
Hinrichsen et al., 2001 
South Carolina 5.4% (5/93)A 
1.0% (857/82,684)A 
1.3% (148/11,562)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
South Dakota 6.0% (270/4,497)A 
0.3% (1/358)A 
Little et al., 2014 
Bowman et al., 2009 
Tennessee 4.4% (2/45)A 
0.6% (670/111,314)A 
0.2% (47/18,891)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Texas 2.1% (20/966)A 
0.5% (1,935/432,919)A 
0.2% (91/58,088)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Utah 0.0% (0/2)A 
1.2% (9/784)A  
0.0% (0/93)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Vermont 33.3% (2/6)A 
14.8% (8,833/59,518)A  
9.9% (368/3,718)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Virginia 20.3% (133/656)A 
9.7% (33,994/350,489)A 
6.7% (1,924/28,787)A 
8.7% (41/472)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Duncan et al., 2005 
Washington 0.0% (0/12)A 
1.5% (64/4,338)A 
0.38% (2/528)A 
0.0% (0/33)A 
Qurollo et al., 2014 
Little et al., 2014 
Carrade et al., 2011 
Bowman et al., 2009 
West Virginia 0.0% (0/2)A 
3.5% (2,152/61,437)A  
0.3% (9/2,942)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Wisconsin 12.1% (7/58)A 
11.8% (33,217/282,663)A 
10.2% (6,018/59,070)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
Wyoming 0.0% (0/1)A 
1.9% (7/361)A  
0.0% (0/184)A 
Qurollo et al., 2014 
Little et al., 2014 
Bowman et al., 2009 
AC6 ELISA; BIFA; CELISA; DWestern Blot; EFlaB PCR; FOspC Multiplex PCR 
Vacc -vaccinated dogs; Non -nonvaccinated dog 
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Table 2: Reported seroprevalence of antibodies to B. burgdorferi in dogs from Canada. 
Province Prevalence (positive/tested) Reference 
Alberta 2.1% (1/48)A 
0.2% (1/584)A 
Qurollo et al., 2014 
Villeneuve et al., 2011 
British Columbia 1.9% (1/53)A 
0.0% (0/418)A 
0.0% (0/88)A 
1.7% (5/287)BD 
Qurollo et al., 2014 
Villeneuve et al., 2011 
Bryan et al., 2011 
Banerjee et al., 1996 
Manitoba 2.4% (303/12,765)A 
0.0% (0/4)A 
1.9% (256/13,456)A 
Herrin et al., (Unpub) 
Qurollo et al., 2014 
Villeneuve et al., 2011 
New Brunswick 3.7% (60/1,631)A 
0.7% (1/151)A 
Herrin et al., (Unpub) 
Villeneuve et al., 2011 
Nova Scotia 15.7% (33/210)A 
2.2% (15/697)A 
0.0% (0/137)C 
Herrin et al., (Unpub) 
Villeneuve et al., 2011 
Bell et al., 1992 
Ontario 2.3% (1,780/77,143)A 
2.4% (4/166)A 
0.5% (270/56,943)A 
1.9% (2/108)A 
1.0% (13/1,318)BCD 
Herrin et al., (Unpub) 
Qurollo et al., 2014 
Villeneuve et al., 2011 
Gary et al., 2006 
Artsob et al., 1993 
Prince Edward 
Island 
0.0% (0/1)A 
10.0% (3/30)A 
1.3% (1/75)A 
Qurollo et al., 2014 
Villeneuve et al., 2011 
Artsob et al., 1992 
Quebec 2.8% (667/23,701)A 
0.0% (0/6)A 
0.6% (76/13,390)A 
Herrin et al., (Unpub) 
Qurollo et al., 2014 
Villeneuve et al., 2011 
Saskatchewan 0.5% (1/186)A 
0.0% (0/7)A 
2.6% (2/77)A 
0.3% (2/582)A 
Herrin et al., (Unpub) 
Qurollo et al., 2014 
Schurer et al., 2014 
Villeneuve et al., 2011 
AC6 ELISA; BIFA; CELISA; DWestern Blot; EFlaB PCR; FOspC Multiplex PCR 
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Table 3: Reported molecular prevalence of Borrelia burgdorferi sensu stricto in ticks from the U.S., 2005 – 2016. 
State Prevalence 
(positive/tested) 
Tick Stage PCR Target Reference 
Alabama1 0.0% (0/1) Nymphs 16S rRNA Diuk-Wasser et al., 2012 
Alaska --    
Arizona --    
Arkansas1 0.0% (0/1) 
53.8% (7/13)  
36.1% (245/678) 
Larvae 
Nymphs 
Adults 
flaB Fyxell et al., 2012 
California2 3.2% (70/2188)  
0.6% (37/6036) 
 
9.5% (7/74) 
1.4% (1/71) 
 
8.1% (119/1,476) 
 
4.9% (264/5431) 
 
6.8% (3/44)  
1.3% (12/904) 
 
0.5% (6/1,108) 
 
0.0% (0/145)  
0.04% (1/2,392) 
 
 
1.2% (2/168) 
Nymphs 
Adults 
 
Nymphs 
Adults 
 
Nymphs 
 
Nymphs 
 
Nymphs 
Adults 
 
Adults 
 
Nymphs 
Adults 
 
 
Adults 
flaB, 16S-23S (rRNA rrs-rrlA)  
 
 
5S-23S rRNA ITS 
 
 
5S-23S rRNA ITS 
 
5S-23S rRNA ITS 
 
gyrB, rpoC, leuS, flaB, ospC, hbb, hbb 
 
 
16S-23S (rrs-rrlA) 
 
5S-23S rRNA ITS, gyrB, rpoC, leuS, 
flaB, ospC, hbb, hbb 
 
 
FL6/FL7 
Padgett et al., 2014 
 
 
Lane et al., 2010 
 
 
Swei et al., 2011 
 
Eisen et al., 2010 
 
Crowder et al., 2010 
 
 
Salkeld et al., 2014 
 
Lane et al., 2013 
 
 
 
Holden et al., 2006 
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Colorado --    
Connecticut1 15.4% (79/514) 
 
23.4% (253/1083) 
 
17.4% (49/281) 
 
67.7% (67/99) 
 
 
22.3% (289/1295) 
Nymphs 
 
Nymphs 
 
Nymphs 
 
Adults 
 
 
Nymphs 
fliD, gB31 
 
16S-23S (rrs-rrlA) 
 
16S rRNA 
 
gyrB, rpoC, leuS, flaB, ospC, hbb, hbb 
 
 
16S-23S (rrs-rrlA) 
Feldman et al., 2015 
 
Diuk-Wasser et al., 2014 
 
Diuk-Wasser et al., 2012 
 
Crowder et al., 2010 
 
 
Hanincová et al., 2006 
Delaware --    
Florida --    
Georgia1 0.0% (0/1) Nymphs 16S rRNA Diuk-Wasser et al., 2012 
Hawaii --    
Idaho --    
Illinois1 9.2% (30/325) 
 
9.4% (3/32) 
 
13.6% (18/132) 
 
35.5% (61/172) 
 
39.4% (5/127) 
Nymphs 
 
Nymphs 
 
Nymphs 
 
Adults 
 
Nymphs, Adults 
16S rRNA 
 
16S-23S (rrs-rrlA) 
 
16S-23S (rrs-rrlA) 
 
ospA, --a 
 
--a 
Diuk-Wasser et al., 2012 
 
Rydzewski et al., 2011 
 
Gatewood et al., 2009 
 
Jobe et al., 2007a 
 
Jobe et al., 2006a 
Indiana1 10.4% (7/67) 
 
23.5% (19/81) 
 
7.7% (1/13) 
 
Nymphs 
 
Adults 
 
Nymphs 
 
16S rRNA 
 
gyrB, rpoC, leuS, flaB, ospC, hbb, hbb 
 
16S-23S (rrs-rrlA) 
 
Diuk-Wasser et al., 2012 
 
Crowder et al., 2010 
 
Gatewood et al., 2009 
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72.0% (72/100) Adults flaB Steiner et al., 2008 
Iowa1 0.0% (0/4) 
 
0.0 – 8.0% (#/#) 
Nymphs 
 
Larvae, 
Nymphs, Adults 
16S rRNA 
 
flaB, --b 
Diuk-Wasser et al., 2012 
 
Lingren et al., 2005b 
Kansas --    
Kentucky1 0.0% (0/2) Nymphs, Adults flaB Taft et al., 2005 
Louisiana1 6.3% (11/174) 
 
11.1% (2/18) 
Adults 
 
Adults 
flaB 
 
flaB 
Leydet Jr et al., 2014 
 
Leydet Jr et al., 2013 
Maine1 42.6% (86/202) 
 
42.8% (3/7) 
 
 
43.6% (82/188) 
 
58.0% (58/100) 
Nymphs 
 
Adults 
 
 
Nymphs 
 
Adults 
16S rRNA 
 
gyrB, rpoC, leuS, flaB, ospC, hbb, hbb 
 
 
16S-23S (rrs-rrlA) 
 
flaB 
Diuk-Wasser et al., 2012 
 
MacQeen et al., 2012 
 
 
Gatewood et al., 2009 
 
Steiner et al., 2008 
Maryland1  19.4% (24/124) 
 
16.9% (85/503) 
 
18.7% (72/385) 
 
14.7% (51/348) 
 
 
11.7% (12/103) 
 
69.2% (9/13)  
60.0% (3/5) 
Nymphs 
 
Nymphs 
 
Nymphs 
 
Nymphs 
 
 
Nymphs 
 
Nymphs 
Adults 
fliD, gB31 
 
16S rRNA 
 
16S-23S (rrs-rrlA) 
 
flaB, gyrB, rpoC, leuS, flaB, ospC, hbb, 
hbb 
 
--b 
 
flaB 
 
Feldman et al., 2015 
 
Diuk-Wasser et al., 2012 
 
Gatewood et al., 2009 
 
Swanson et al., 2007 
 
 
Giery et al., 2007b 
 
Anderson et al., 2006 
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12.8% (5/39) 
 
Nymphs, Adults 
 
flaB 
 
Taft et al., 2005 
Massachusetts1 20.7% (18/87) 
 
12.3% (17/138) 
 
0.0% (0/56) 
Nymphs 
 
Nymphs 
 
Nymphs, Adults 
16S-23S (rrs-rrlA) 
 
16S rRNA 
 
flaB 
Diuk-Wasser et al., 2014 
 
Diuk-Wasser et al., 2012 
 
Taft et al., 2005 
Michigan1 12.4% (22/178) 
 
26.4% (39/148)  
44.3% (39/88)  
9.4% (6/64) 
49.1% (53/108) 
 
9.3% (8/246) 
36.6% (31/86) 
 
12.7% (20/157) 
 
33.3% (6/18) 
Nymphs 
 
Larval Pool 
Nymphs on 
Host 
Nymphs 
Adults 
 
Nymphs 
Adults 
 
Nymphs 
 
Adults 
16S rRNA 
 
16S-23S (rrs-rrlA) 
 
 
 
 
16S-23S (rrs-rrlA) 
 
 
16S-23S (rrs-rrlA) 
 
16S-23S (rrs-rrlA) 
Diuk-Wasser et al., 2012 
 
Hamer et al., 2012 
 
 
 
 
Hamer et al., 2010 
 
 
Gatewood et al., 2009 
 
Hamer et al., 2009 
Minnesota1 25.9% (90/348) 
37.5% (157/419) 
 
34.7% (125/360) 
 
32.1% (87/271) 
Nymphs 
Adults 
 
Nymphs 
 
Nymphs 
flaB 
 
 
16S rRNA 
 
16S-23S (rrs-rrlA) 
Stromdahl et al., 2014 
 
 
Diuk-Wasser et al., 2012 
 
Gatewood et al., 2009 
Mississippi1 0.0% (0/6)  
0.0% (0/256) 
Nymphs 
Adults 
flaB Goltz et al., 2013 
Missouri1 0.0% (0/3) Nymphs 16S rRNA Diuk-Wasser et al., 2012 
Montana --    
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Nebraska --    
Nevada --    
New Hampshire1 0.0% (0/8) 
 
60.1% (306/509) 
Nymphs 
 
Adults 
16S rRNA 
 
--# 
Diuk-Wasser et al., 2012 
 
Walk et al., 2009# 
New Jersey1 13.0% (62/478)  
51.5% (314/610) 
 
19.5% (25/128) 
 
25.6% (40/156) 
 
22.9% (8/35) 
 
31.9% (30/94) 
 
17.6% (44/250) 
 
 
4.4% (3/68) 
 
54.4% (80/147) 
Nymphs 
Adults 
 
Nymphs 
 
Nymphs 
 
Nymphs 
 
Adults 
 
Nymphs 
 
 
Nymphs, Adults 
 
Adults 
flaB 
 
 
16S rRNA 
 
fliD 
 
16S-23S (rrs-rrlA) 
 
flaB 
 
flaB, 16S-23S (rrs-rrlA),  ospA 
 
 
flaB 
 
16S-23S (rrs-rrlA) 
Schulze et al., 2013 
 
 
Diuk-Wasser et al., 2012 
 
Dolan et al., 2011 
 
Gatewood et al., 2009 
 
Schulze et al., 2006 
 
Ullmann et al., 2005 
 
 
Taft et al., 2005 
 
Schulze et al., 2005 
New Mexico --    
New York1 23.3% (48/207) 
 
28.5% (1245/4368) 
 
34.3% (23/67) 
23.0% (129/561) 
 
14.5% (478/3,300)  
Nymphs 
 
Nymphs 
 
Nymphs 
Adults 
 
Nymphs 
fliD, gB31 
 
23S rRNA 
 
ospA 
 
 
16S rRNA 
Feldman et al., 2015 
 
Hersh et al., 2014 
 
Aliota et al., 2014 
 
 
Prusinski et al., 2014 
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43.7% (3,448/7,884) 
 
17.0% (232/1367) 
 
22.4% (22/98) 
59.6% (133/223) 
 
63.6% (182/286) 
 
21.3% (267/1,256) 
 
17.2% (5/29) 
 
37.3% (91/244)  
36.4% (32/88) 
 
3.2% (1/31) 
Adults 
 
Nymphs 
 
Nymphs 
Adults 
 
Adults 
 
Nymphs 
 
Nymphs 
 
Nymphs 
Adults 
 
Nymphs, Adults 
 
 
16S rRNA 
 
gyrB, rpoC, leuS, flaB, ospC, hbb, hbb 
 
 
flaB, ospA 
 
16S-23S (rrs-rrlA) 
 
--b 
 
16S rRNA 
 
 
flaB 
 
 
Diuk-Wasser et al., 2012 
 
Crowder et al., 2010 
 
 
Tokarz et al., 2010 
 
Gatewood et al., 2009 
 
Giery et al., 2007b 
 
Moreno et al., 2005 
 
 
Taft et al., 2005 
North Carolina1,3 0.0% (0/5) 
 
0.0% (0/298)1  
33.5% (52/155)3 
 
0.0% (0/4) 
Nymphs 
 
Adults 
Adults 
 
Nymphs, Adults 
16S rRNA 
 
16S-23S (rrs-rrlA) 
 
 
flaB 
Diuk-Wasser et al., 2012 
 
Maggi et al., 2010 
 
 
Taft et al., 2005 
North Dakota1 0.0% (0/15)  
2.2% (1/45)  
6.3% (2/32) 
Larvae 
Nymphs 
Adults 
flaB Russart et al., 2014 
Ohio1 13.5% (7/52)  
3.6% (8/221) 
Nymphs 
Adults 
flaB Wang et al., 2014 
Oklahoma1 0.0% (0/5) Nymphs 16S rRNA Diuk-Wasser et al., 2012 
Oregon2 2.1% (35/1,689) Adults 16S rRNA Doggett et al., 2008 
Pennsylvania1 46.0%  (854/1855) Adults flaB Hutchinson et al., 2015 
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35.1% (114/325) 
 
17.6% (13/74) 
26.8% (11/41) 
 
19.7% (59/300)  
35.2% (82/233) 
 
23.4% (51/218) 
 
19.5% (24/123) 
 
55.3 (52/94) 
 
0.0% (0/47) 
 
Adults 
 
Nymphs 
Adults 
 
Nymphs 
Adults 
 
Nymphs 
 
Nymphs 
 
Adults 
 
Nymphs, Adults 
 
flaB 
 
flaB 
 
 
flaB 
 
 
16S rRNA 
 
16S-23S (rrs-rrlA) 
 
flaB 
 
flaB 
 
Brown et al., 2015 
 
Han et al., 2014 
 
 
Stromdahl et al., 2014 
 
 
Diuk-Wasser et al., 2012 
 
Gatewood et al., 2009 
 
Steiner et al., 2008 
 
Taft et al., 2005 
Rhode Island1 19.5% (15/77) 
 
15.8% (456/2884) 
Nymphs 
 
Nymphs 
16S rRNA 
 
--b 
Diuk-Wasser et al., 2012 
 
Connally et al., 2006b 
South Carolina1 0.0% (0/2) Nymphs 16S rRNA Diuk-Wasser et al., 2012 
South Dakota --    
Tennessee1 0.0% (0/47) 
 
-0.0% (0/883) 
Adults 
 
Adults 
flaB, 23S rRNA 
 
16S rRNA 
Mays et al., 2014 
 
Rosen et al., 2012 
Texas1 1.6% (1/62) 
 
50.0% (37/74)* 
 
11.1% (1/9)  
0.0% (0/67) 
Adults 
 
Adults 
 
Nymphs 
Adults 
flaB 
 
flaB, 16S-23S (rrs-rrlA) 
 
flaB 
Mitchell et al., 2016 
 
Feria-Arroyo et al., 2014 
 
Williamson et al., 2010 
Utah2 0.0% (0/119)  fliD Davis et al., 2015 
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Vermont1 0.0% (0/16) 
 
0.0% (0/16) 
Nymphs 
 
Nymphs 
16S rRNA 
 
16S-23S (rrs-rrlA) 
Diuk-Wasser et al., 2012 
 
Gatewood et al., 2009 
Virginia1 32.9% (117/356) 
 
15.8% (48/304) 
 
10.6% (7/66) 
 
0.0% (0/7) 
 
25.0% (8/32) 
Adults 
 
Nymphs 
 
Nymphs 
 
Nymphs 
 
Nymphs, Adults 
flaB 
 
16S rRNA 
 
16S rRNA 
 
16S-23S (rrs-rrlA) 
 
flaB 
Herrin et al., 2014 
 
Brinkerhoff et al., 2014 
 
Diuk-Wasser et al., 2012 
 
Gatewood et al., 2009 
 
Taft et al., 2005 
Washington2 --    
West Virginia --    
Wisconsin1 35.7% (122/321)F 
 
19.8% (95/480)  
25.9% (52/201) 
 
27.9% (339/1,214) 
 
18.7% (284/1517) 
 
17.4% (234/1346) 
 
35.0% (35/100) 
 
0.0% (0/157) 
14.3% (1/7)  
4.2% (5/118) 
Adults 
 
Nymphs 
Adults 
 
Nymphs 
 
Nymphs 
 
Nymphs 
 
Adults 
 
Larvae 
Nymphs 
Adults 
recA 
 
flaB 
 
 
ospB 
 
16S rRNA 
 
16S-23S (rrs-rrlA) 
 
flaB 
 
ospB 
Turtinen et al., 2015 
 
Stromdahl et al., 2014 
 
 
Lee et al., 2014 
 
Diuk-Wasser et al., 2012 
 
Gatewood et al., 2009 
 
Steiner et al., 2008 
 
Caporale et al., 2005 
Wyoming --    
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aCulture; bIFA 
#Information not reported 
*Results have been disputed in the literature (Norris et al., 2014; Esteve-Gassent et al., 2015; Norris et al., 2015) 
1I. scapularis; 2I. pacificus; 3I. affinis 
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Table 4: Reported molecular prevalence of Borrelia burgdorferi sensu stricto in ticks from Canada, 2005 – 2016. 
Province Prevalence 
(positive/tested) 
Tick Stage PCR Target Reference 
Alberta1 13.8% (12/87) Nymph, Adult ospA, 23S rRNA Dibernardo et al., 2014 
British Columbia2 0.5% (1/192) 
4.1% (4/98)  
0.0% (0/13) 
Larval Pool 
Nymphal Pool 
Adult Pool 
23S rRNA Morshed et al., 2015 
 
 
Manitoba1 8.8% (15/170) 
 
9.7% (34/349) 
Nymphs, Adults 
 
Adults 
ospA, 23S rRNA 
 
Multiple PCR targets 
Dibernardo et al., 2014 
 
Ogden et al., 2006 
New Brunswick1 25.0% (1/4) 
 
6.8% (25/366) 
 
15.9% (24/151) 
Adults 
 
Nymphs, Adults 
 
Adults 
ospA, 23S rRNA 
 
ospA, 23S rRNA 
 
Multiple PCR targets 
Gabriele-Rivet et al., 2015 
 
Dibernardo et al., 2014 
 
Ogden et al., 200 
Newfoundland1 27.3% (9/33) 
 
19.0% (4/21) 
Nymphs, Adults 
 
Adults 
ospA, 23S rRNA 
 
Multiple PCR targets 
Dibernardo et al., 2014 
 
Ogden et al., 2006 
Nova Scotia1 11.8% (4/34) 
 
15.1% (13/86) 
Nymphs, Adults 
 
Adults 
ospA, 23S rRNA 
 
Multiple PCR targets 
Dibernardo et al., 2014 
 
Ogden et al., 2006 
Ontario1 41.3% (12/29) 
 
11.3% (32/283)  
15.1% (873/5,763) 
 
15.9% (411/2,591) 
 
66.7% (10/15) 
 
Adults 
 
Nymphs 
Adults 
 
Nymphs, Adults 
 
Adult Pool 
 
flaB 
 
ospA, 23S rRNA 
 
 
ospA, 23S rRNA 
 
ospA, multiple PCR targets 
 
Scott et al., 2016 
 
Nelder et al., 2014 
 
 
Dibernardo et al., 2014 
 
Scott et al., 2008 
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11.1% (5/45) 
 
12.9% (42/325) 
Adults 
 
Adults 
Multiple PCR targets 
 
Multiple PCR targets 
Ogden et al., 2006 
 
Morshed et al., 2006 
Prince Edward 
Island1 
9.6% (17/178) 
 
11.1% (20/180) 
Nymphs, Adults 
 
Adults 
ospA, 23S rRNA 
 
Multiple PCR targets 
Dibernardo et al., 2014 
 
Ogden et al., 2006 
Quebec1 13.7% (203/1,479) 
 
3.3% (8/243) 
 
2.3% (12/533)  
7.8% (18/232)  
8.5% (377/4,323) 
 
13.2% (128/984) 
Nymphs, Adults 
 
Adults 
 
Larvae  
Nymphs 
Adults 
ospA, 23S rRNA 
 
23S rRNA 
 
Multiple PCR targets 
 
 
 
Multiple PCR targets 
Dibernardo et al., 2014 
 
Bouchard et al., 2013 
 
Ogden et al., 2010 
 
 
 
Ogden et al., 2006 
Saskatchewan --    
1I. scapularis; 2I. pacificus 
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CHAPTER III 
 
 
CONFIRMATION OF BORRELIA BURGDORFERI SENSU STRICTO AND 
ANAPLASMA PHAGOCYTOPHILUM IN NEWLY ESTABLISHED 
POPULATIONS OF IXODES SCAPULARIS, SOUTHWESTERN VIRGINIA1 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Herrin, B.H., Zajac, A.M., Little, S.E., 2014. Vector-Borne and Zoonotic Diseases 
14(11):821–823. Reprinted here with permission of publisher. 
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ABSTRACT 
To determine the prevalence of Borrelia burgdorferi and Anaplasma 
phagocytophilum in a newly established population of Ixodes scapularis in the 
mountainous region of southwestern Virginia, questing adult ticks were collected and the 
identity and infection status of each tick confirmed by PCR and sequencing. A total of 
364 adult ticks were tested from three field sites. B. burgdorferi sensu stricto was 
identified in a total of 32/101 (32%) ticks from site A, 49/154 (32%) ticks from site B, 
and 36/101 (36%) ticks from site C, for a total prevalence of 33% (117/356). In addition, 
A. phagocytophilum was detected in 3/364 (0.8%) ticks, one from Site A and two from 
Site B. The prevalence of both pathogens in ticks at these sites is similar to that reported 
from established endemic areas. These data document the presence of I. scapularis and 
the agent of Lyme disease in a newly established Appalachian region, providing further 
evidence of range expansion of both the tick and public and veterinary health risk it 
creates. 
Key Words: Anaplasma phagocytophilum, Borrelia burgdorferi, Ixodes scapuarlis, 
Virginia 
 
INTRODUCTION 
In the northeastern and upper midwestern regions of the United States, Ixodes 
scapularis (Acari: Ixodidae) is the vector for both Borrelia burgdorferi sensu stricto 
(Spirochaetales: Spirochaetaceae), the causative agent of Lyme disease (LD) in the U.S., 
and Anaplasma phagocytophilum (Ricketsiales: Anaplamataceae), the causative agent of 
human granulocytic anaplasmosis (HGA). Ticks harboring B. burgdorferi have been 
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documented from the northeastern and coastal regions of Virginia, and from coastal 
North Carolina, but there have been no published reports from the adjacent mountainous, 
Appalachian regions of these states (Maggi et al. 2010; Nadolny et al. 2011).  
The expanding number of human Lyme borreliosis (LB) cases reported each year 
renders accurate determination of the geographic range where B. burgdorferi poses a 
potential infectious threat increasingly important. The present study sought to confirm the 
presence and determine the prevalence of B. burgdorferi and A. phagocytophilum in I. 
scapularis collected from a newly endemic region of southwestern Virginia.  
 
MATERIAL AND METHODS 
Questing adult Ixodes spp. ticks were collected from October 2012 through April 
2013 by standard cloth drags at three sites in Giles County and Pulaski County, Virginia. 
Sites selected for dragging included both public recreational land and low-density private 
residential communities with mixed hardwood habitat. Site A is a public park bordered 
by woody edge habitat and a river, Site B is a wooded, low-density residential area, and 
Site C is a grassy and wooded area near a playground at a recreational lake. Ticks were 
placed in 70% ethanol at the time of collection and held at room temperature until 
processed for PCR. 
Individual ticks were identified morphologically by comparison to standard keys 
(USDA Ag Handbook 485, 1976) and then dissected and total nucleic acid extracted as 
previously described. Briefly, internal tick contents were digested in a proteinase K lysis 
buffer, the DNA extracted with phenol/chloroform, resuspended in 50µl of buffer, and 
stored at -80°C (Halos et al. 2004). Nucleic acid extracts from each tick were individually 
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tested by PCR to confirm tick species, and for B. burgdorferi and A. phagocytophilum as 
previously described (Little et al. 1997, Stromdahl et al. 2003, Macaluso et al. 2003, 
Nadolny et al. 2011). Amplicons were purified using a commercial kit (Wizard 
Genomic DNA Purification Kit, Promega, Fitchburg, WI) according to manufacturer’s 
guidelines and sequenced directly (SmartSeq, eurofins genomics, Huntsville, AL).  
Sequence analysis and alignment was performed using MacVector software 
(MacVector, Inc., Cary, NC). Sequences generated from study samples were compared 
with published sequences using the nucleotide Basic Local Alignment Search Tool 
(BLASTn, National Center for Biotechnology Information, Bethesda, MD). Differences 
in prevalence of B. burgdorferi in ticks between collection sites and tick gender were 
evaluated for significance with a Pearson’s chi-squared test using Excel (Microsoft 2008, 
Redmond, WA) with significance assigned at P < 0.05.   
   
RESULTS 
A total of 356 adult ticks (202 female, 154 male) were collected from the three 
sites. All ticks were morphologically and molecularly identified as I. scapularis 
(GenBank L43862.1). Borrelia burgdorferi sensu stricto was detected in 32/101 ticks 
(31.7%) from site A, 49/154 ticks (31.8%) from site B, and 36/101 ticks (35.6%) from 
site C, for a total prevalence of 32.9% (117/356). Female I. scapularis were more likely 
(P < 0.05) to be PCR positive for B. burgdorferi (75/202; 37.1%) than male (42/154; 
27.3%). Anaplasma phagocytophilum was detected by PCR in 3/356 ticks (0.8%), one 
from site A in a ticks in which B. burgdorferi was not detected, and two from site B co-
infected with both agents. No A. phagocytophilum was detected in ticks from Site C. All 
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sequences showed between 99% and 100% identity with corresponding GenBank 
sequences (B. burgdorferi CP001205.1, A. phagocytophilum JN181070.1).  
 
DISCUSSION 
This study documents B. burgdorferi sensu stricto in high prevalence in questing 
I. scapularis ticks outside of the area traditionally considered endemic for Lyme 
borreliosis (LB), suggesting recent expansion of this disease system into the southern 
Appalachian region. The prevalence of these pathogens in adult ticks is comparable to 
those previously reported from endemic areas in the northeastern U.S. (Adelson et al. 
2004, Holman et al. 2004). Geographic expansion of LB in North America has been 
noted by others including in Canada and the midwestern U. S. (Ogden et al. 2010; Hamer 
et al. 2010).  
When accurate, geographic distribution patterns can aid proper diagnosis of LB in 
humans and dogs. However, this approach can be complicated by expanding field 
ecology and the presence of a number of other species in the B. burgdorferi sensu lato 
group in a given area, making identification of pathogens in field collected ticks 
important ( Rudenko et al. 2011). Anaplasma phagocytophilum, an agent of both human 
and veterinary disease, was also detected in the ticks in the present study; both 
pathogenic and apparently non-pathogenic variants of A. phagocytophilum have been 
described (Massung et al. 2003).  
These data confirm that populations of I. scapularis harboring both B. burgdorferi 
and A. phagocytophilum are established in southwestern Virginia; additional 
investigations in other areas of southern Appalachia are needed. Recent reports indicate 
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that I. scapularis ticks have also expanded their range in neighboring West Virginia, 
together with increased reports of LB from this region (WVDHHR, 2012). Field research 
documenting the expanding geographic range of these disease agents is important to 
support prompt diagnosis and treatment of human and canine LB.  
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AREA, 2000-20101 
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ABSTRACT 
Lyme borreliosis (LB) is endemic within the New York City metropolitan area, a 
large region with habitat and demographic diversity.  Results from 175,259 canine 
serologic tests for specific antibodies to Borrelia burgdorferi, the agent of LB in the 
United States, were evaluated to compare infection in dogs to reported human cases and 
other environmental and social parameters. Initial evaluation of categorical data revealed 
a gradient of prevalence radiating outwards from the most densely populated areas of the 
region, with the highest seroprevalence in dogs (21.1%) in areas with greater than 50% 
forested area. Multiple regression with several environmental risk factors provided an 
accurate prediction of infection in dogs (adjusted R2 = 0.90) but was less accurate at 
predicting human case reports (R2= 0.74). Analysis of canine serologic data continues to 
be a valuable tool for understanding transmission of zoonotic tick-borne disease agents. 
Article Summary 
Canine seroprevalence accurately predicted risk of infection with Borrelia burgdorferi 
for both dogs and humans in the New York City metropolitan area and can be used to 
identify environments that are suitable for the maintenance of B. burgdorferi in regions 
where Lyme borreliosis is confirmed to be endemic.  
Keywords 
Canine, Lyme borreliosis, Borrelia burgdorferi, 4Dx SNAP, epidemiology 
 
INTRODUCTION 
 Lyme borreliosis (LB) caused by Borrelia burgdorferi sensu stricto is the most 
frequently reported vector-borne disease in people in the United States (1). Infection and 
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disease is common in people and dogs in the northeastern United States, with the 
majority (95%) of all human cases being reported from 13 northeastern states, including 
9.7% from New York state alone (2). Exposure to B. burgdorferi in dogs parallels that in 
humans; the majority of dogs with detectable antibodies are identified in the Northeast, 
and 7.1% of pet dogs in New York state are seropositive (3, 4). Humans and dogs are 
both considered incidental hosts, acquiring the pathogen through the bite of an Ixodes 
spp. tick. Once infected, most human patients develop a distinctive erythema migrans 
rash, fever, headache, joint and muscle pain, and fatigue; if left untreated, disease may 
progress to more serious cardiac, articular, and neurologic conditions (5). Since its initial 
description in 1975, Lyme disease has continued to increase in range and incidence 
throughout the northeastern and upper midwestern United States and southern Canada (2, 
6).   
On a local level, the risk of infection with a tick-borne disease agent is directly 
related to exposure risk, which in turn is associated with lifestyle. For example, 
seroprevalence of people to Ehrlichia chaffeensis has been shown to be associated with a 
variety of risk factors, including frequency and number of tick bites, use of repellents, 
and even golf scores (12). Similar risk factors have been analyzed for Lyme disease and 
include everything from sightings of deer, a key reproductive host for the tick vector, to 
habitat factors such as oak trees and acorns, which provide mast to support higher rodent 
reservoir populations (13). Many studies focus on the deer/human interface, citing 
evidence that suggests increased contact with deer, such as automobile-deer collisions, 
correlates with increased risk of infection with B. burgdorferi (14, 15). A diverse and low 
disturbance ecosystem appears to decrease infection risk, presumably due to the presence 
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of less competent reservoirs which serve as dilutional hosts (16, 17). Areas with a high 
vegetation index (e.g. NDVI, normalized difference vegetation index), especially 
deciduous forests that provide ideal tick habitats, increase risk, while grasslands are 
typically associated with a lower risk of infection (18, 19).  
A number of previous studies on B. burgdorferi transmission have relied on 
quantitative tick collection methods and pathogen testing, as well as environmental 
factors influencing wildlife reservoirs and vector ticks (20, 6, 21, 22). Domestic dogs 
have also proven to be valuable sentinels for tick-borne disease agents, allowing 
identification of areas where transmission is occurring (7 – 11). Pet dogs share a common 
habitat and environment with their owners and thus can serve as bellwethers of human 
infection risk. Using a comprehensive database generated by testing dogs throughout the 
United States, we recently described areas where canine heartworm infection and tick-
borne disease exposure were common (3, 4). In the present paper, we provide a more 
detailed analysis of a geographically and demographically diverse area where LB is 
endemic in people and dogs.  
 
METHODS 
Study Area 
The New York City Metropolitan Statistical Area (NYC MSA) plus 3 additional, 
contiguous counties in Connecticut (Litchfield, New Haven, and Fairfield) comprise the 
complete study area. The NYC MSA is titled the New York-Newark-Bridgeport, NY-NJ-
PA Metropolitan Statistical Area, and includes a population of 20.1 million people by 
2014 Census estimates, combined with the surrounding counties for a total population of 
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approximately 22 million people (23). The area was selected not only for the large 
population and data available, but also for the dramatically diverse population density 
and environment types, with central NYC representing an urban area, and the outer 
counties, including Pike, PA, more exurban with transitional counties between them. This 
gradient allowed the analysis of a variety of environmental and social factors within an 
area where LB is endemic.  
Qualitative Serology 
 Percent positive canine test results for B. burgdorferi by county were obtained 
from a national reporting system created for veterinarians and maintained by IDEXX 
Laboratories, Inc. (Westbrook, ME). Briefly, veterinary practices routinely testing dogs 
for antibodies to B. burgdorferi submitted their results through a centralized system. Data 
were collated and tallied according to location of the veterinary practice reporting results 
and then sorted according to county and state (3, 4). A total of 175,259 dogs were tested 
over a 10 year period, 2000-2010, in the NYC MSA and adjacent counties. All qualitative 
testing was conducted using in-clinic SNAP3Dx Test kit or SNAP4Dx Test kit 
(IDEXX Laboratories, Westbrook, ME), in-clinic ELISA tests for simultaneous detection 
of canine antibodies to E. canis, B. burgdorferi and Anaplasma phagocytophilum,  and 
Dirofilaria immitis antigen. The in-clinic ELISAs include a C6 peptide-based assay that 
detects antibodies to B. burgdorferi with a sensitivity of 94.4% compared to a 
combination of immunofluorescence assay (IFA) and Western blot (WB) (24), a 
specificity of 99.6% on field samples (7), and does not react to antibodies generated by 
vaccination (25, 26).  
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Social and Environmental Variables 
Variables included in the initial categorical analysis were: population density (27, 
28), median household income (28), percent forested area (29), percent canine samples 
positive for antibody to B. burgdorferi, and human cases per year as reported by the CDC 
per 100,000 people between 2002 and 2006 (30). All variables were summarized and 
analyzed at the county level.  
For regression, more specific environmental variables were added (Table 1), 
including minimum and maximum temperature and precipitation in November. 
November was selected to reflect a period immediately following peak questing activity 
of adult ticks in which egg deposition and larval development occurs. Temperature and 
precipitation values between months co-vary, precluding use of the same data from 
multiple months. We downloaded 1 km resolution November minimum and maximum 
temperature and precipitation from PRISM climate group 
(http://www.prism.oregonstate.edu/) for 2000-2009, and calculated the averages for this 
period, by county.  In addition, more specific land cover types replaced percent forested 
area, including: open water, barren land, deciduous forest, evergreen forest, mixed forest, 
pasture/hay, shrub/scrub, grassland/herbaceous, cultivated crops, woody wetlands, and 
emergent herbaceous wetlands. These represent the available land cover classes in the US 
Geological Survey National Land Cover Database for 2006, derived from Landsat 
satellite imagery with 30 m resolution (31). For each county, we calculated % land cover 
type. The same dataset contains four classes of intensity of development, which we used 
to supplement population density, namely: no (open space, <20% impervious surfaces), 
low (20-49% impervious surfaces), medium (50-79% impervious surfaces), or high (80-
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100% impervious surfaces) intensity development. Finally, we included the normalized 
difference vegetation index (NDVI) for November, derived from Moderate Resolution 
Imaging Spectroradiometer (MODIS) satellite data for 2000-2009, averaged by county 
(32). 
Statistical Analysis 
Initial analysis of the categorical data was performed using Excel (Microsoft 
2007). The variables were split into 2 or 3 groups, and then a 2-tailed Student’s T-test 
was performed. Variables included percent positive canine tests (0-10%, 10-20%, >20%), 
human case reports per 100,000 people (<10, 10-100, >100), population density (<2500, 
2500-7500, >7500 person/sq mi), median household income (<$70,000, >$70,000), and 
percent forested area (<25%, 25-50%, >50%). Subsequent analyses using more specific 
environmental data (Table 1) were performed using StatPlus (AnalystSoft, Alexandria, 
VA), with significance assessed at p < 0.05. An initial simple regression was performed 
with each variable and either percent positive canine tests or human case reports.  All 
variables that were significant by simple regression were analyzed pair-wise using a 
Pearson’s Correlation Test; the significance of any two variables with a correlation value 
over 0.9 (ρ > 0.9) was assessed and variables that did not contribute significantly to 
further analysis were removed (33), then multiple backwards-stepwise regression 
performed on remaining significant variables. For analysis of percent positive canine tests 
against the environmental and social variables, five elimination steps were performed. 
For the analysis of human case reports, nine elimination steps were performed.  
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RESULTS 
Percent positive canine tests for B. burgdorferi ranged from 1.2% in Queens 
County, NY to 27.3% in Putnam County, NY (Figure 1). Population-adjusted case reports 
of human LB followed the same general trend, ranging from 0.50 case reports/105 in 
Orange County, NY to 438.71 case reports/105 in Dutchess County, NY.  
Initial categorical analysis revealed percent positive canine tests were 
significantly higher in counties with population density < 2,500 persons/sq mi (17.9%, 
pAB = 0.004) than in counties with population density 2,500-7,500 persons/sq mi (8.0%) 
or > 7,500 persons/sq mi (5.1%). Percent positive canine tests did not differ significantly 
between counties with moderate and high population density (pBB = 0.16). Population 
adjusted human case reports were also significantly higher in counties with population 
density < 2,500 persons/sq mi (113.4 case reports/105, pAB = 0.002), and counties with 
population density 2,500-7,500 persons/sq mi (10.2 case reports/105, pAB = 0.002) than in 
counties with > 7,500 persons/sq mi (3.4 case reports/105). No significant difference was 
seen in percent positive canine tests (p = 0.91) or human case reports (p = 0.83) between 
counties with median income < $70,000 (15.3%, 66.5 case reports/105) and those with 
median income >$70,000 (13.6%, 74.9 case reports/105).  
Percent positive canine tests were significantly higher in counties with > 50% 
forested area (21.1%) than those with 25-50% forested area (15.3% , pBC = 0.026) 
and<25% forested area (6.3%, pAC < 0.0001).  Percent positive canine tests in counties 
with 25-50% forested areas were also significantly greater than those with <25% forested 
area (pAB = 0.002). Population adjusted human case reports were also significantly higher 
in counties with 25-50% (66.0 case reports/105) or > 50% forested area (164.7 case 
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reports/105) than in counties with <25% forested area (11.1 case reports/105, pAB = 0.045, 
pAC = 0.0048), but did not differ significantly between densely and moderately forested 
counties (pBB = 0.065).  
Percent positive canine tests were significantly lower in counties with < 10 human 
case reports/105 (8.3%) than those with 10-100 human case reports/105 (13.7%, pAB = 
0.005) or those with >100 case reports/105 (24.0%, pBC < 0.0001). Similarly, human case 
reports of LB were significantly lower in counties with <10% positive canine test results 
(13.1 case reports/105, pAB = 0.008, pAC = 0.00012) and counties with 10-20% positive 
canine test results (38.9 case reports/105, pBC = 0.0017) than counties with > 20% positive 
canine test results (197.0 case reports/105). 
By simple regression, canine percent positive tests were highly correlated with 
population adjusted human case reports (p < 0.00001; R2 = 0.47). When compared to 
several environmental and social factors (Table 1), both canine percent positive tests and 
population adjusted human case reports significantly correlated with minimum and 
maximum temperature in November; NDVI for November; low, medium, and high-
developed intensity; deciduous forest; and pasture/hay area (Table 1). Canine percent 
positive tests also correlated with population density, mixed forest area, and emergent 
herbaceous wetland, while human case reports correlated with shrub/scrub area (Table 1). 
Pearson’s correlation coefficient tests identified covariance between several factors, 
resulting in removal of November NDVI and developed high intensity area. Remaining 
factors that were significant for either canine percent positive tests or population adjusted 
human case reports were used in subsequent multiple backwards-stepwise regressions 
(Table 1).  
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For the backwards-stepwise regressions based on percent positive canine tests, 11 
factors were initially considered. After five elimination steps, remaining significant 
factors were human case reports per 100,000 people, population density, maximum 
temperature in November, deciduous forested area, mixed forest area, and precipitation in 
November (Table 2). Using B values for each factor and the constant (Table 2), the 
predicted percent positive tests generated using the regression compared closely to the 
actual values reported (R2 = 0.88; Figure 2). 
For the analysis based on human case reports, 11 factors were initially considered. 
After nine elimination steps, remaining significant factors were percent positive canine 
tests and pasture/hay area (Table 3). Again, the B values and constants (Table 3) used to 
predict the human case reports compared to the actual numbers reported (R2 = 0.63; 
Figure 3).  
 
DISCUSSION 
Approximately 1 in 16 people in the United States live in the New York City 
metropolitan statistical area (23). In general, dog ownership follows human population 
trends; nationally 36.5% of households own one or more dogs although ownership rates 
vary somewhat geographically (34). This region proved ideal for an in depth analysis of 
risk factors for B. burgdorferi transmission due to established endemicity for Lyme 
borreliosis (LB) throughout the area, a robust dataset on canine seroprevalence, public 
availability of human case reports of LB by county, and the presence of dramatically 
diverse habitat factors in close geographic proximity. The large sample size, which 
included 175,259 test results generated by practicing veterinarians over 10 years, allowed 
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detailed analysis of environmental and social variables that may contribute to the risk of 
infection. Similar analyses attempted over larger geographic regions may be complicated 
by variations in tick phenology, reservoir host composition, habitat, or inclusion of data 
from non-endemic areas when analysis is attempted in transitional zones where 
maintenance cycles for B. burgdorferi have only recently expanded.  
Key variables identified as important for predicting infection risk to dogs in this 
study included factors that are biologically relevant to supporting tick populations and 
have been shown to be important in previous studies, such as deciduous forest, mixed 
forest, precipitation, and temperature, and not those variables considered detrimental to 
tick habitat such as evergreen forest, wet habitat, and rocky or barren land (13, 15, 20, 
35). Both deciduous and mixed forests provide leaf litter considered important as tick 
habitat, while temperature and precipitation combine to provide adequate humidity for 
ticks to thrive (36). Canine serology is likely a strong basis for the model because 
serologic testing for past or current infection with B. burgdorferi is routinely performed 
in veterinary practices on both healthy and sick animals, generating survey data that 
represent cross-sectional infection risk in a large portion of the canine population. 
The significant variables used to predict human case reports provided less 
information about the type of environment which would be considered high risk for 
contracting LB, with the only significant factors being canine positive tests and 
pasture/hay area. While pasture area may represent outdoor or forest-edge activity, it is 
not considered ideal I. scapularis habitat (19). However, farmland and pastures are often 
converted to new housing developments and thus may serve as a focus for human 
population and subsequent infection risk. In comparison to canine serology, mapping risk 
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of infection by analysis of human case reports appeared to be less accurate in identifying 
high-risk areas. This shortcoming is most likely due to reliance on clinical or laboratory 
confirmation of disease in the human case report data as well as bias due to variations in 
physician visits, patient access to medical care, and reporting bias. Similar issues are 
thought to contribute to a dramatic underestimation of the number of cases of LB that 
occur each year in the United States (37).  
The role of population density in creating risk for infection with B. burgdorferi is 
best considered in combination with environmental and social variables. The most 
densely populated areas of the region do not pose a high risk for infection due to the 
predominantly urban environment, and nor do rural, isolated areas that people or dogs 
rarely enter. Human and canine traffic in suitable habitat is key to creating risk. This 
crossroads phenomenon has been previously described using forest fragmentation, which 
presumably breaks the forest into smaller areas, allowing more human and canine 
exposure to forest edge habitat, and thus tick exposure (38, 39). The present study is 
unable to address these two competing forces at the same time, but the data did show a 
consistent trend to under-predict both canine positive tests and human case reports in the 
more populous areas, including Queens, Bronx, Hudson, Kings, and New York counties 
(Figure 2 & 3). These counties appear to have a higher than expected seroprevalence of 
canine infection with B. burgdorferi, supporting the interpretation that many canine and 
human infections are acquired when travelling outside more urban areas of the NYC 
MSA.  
 Like all analyses applied to the natural environment, the present study has 
limitations. The environmental and social variables used in the analysis have all been 
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averaged or calculated for the entire ten-year study period to reduce fluctuations that may 
introduce bias. This approach provides a steady value for each variable, but also 
constrains the results within the time period evaluated; accordingly, our results may not 
accurately predict cases of LB in the future due to changes in environmental and social 
variables over time. Moreover, the canine data is only available on a county level, and 
habitat characteristics can vary widely within a county, limiting the resolution of any 
analysis. Available data about human case reports by county were also sparse. Despite 
these limitations, we were able to use specific (C6) canine serology and selected 
environmental factors to accurately predict risk of infection in an endemic area. However, 
this strategy likely should be adjusted before applying to other endemic regions and 
would only be expected to have value in areas where autochthonous transmission of B. 
burgdorferi is confirmed to occur. Endemic areas are best identified by the presence of 
infected vector ticks together with laboratory-confirmed evidence of local transmission of 
that infection to people or dogs. In non-endemic areas, antibodies reactive to B. 
burgdorferi in dogs can be attributed to the use of non-specific assays or the result of 
testing dogs translocated from regions where a maintenance cycle is known to exist (3, 4, 
7, 40, 41). 
 
CONCLUSIONS 
 Evidence of past or current infection with Borrelia burgdorferi is common in 
dogs in the New York City metropolitan area, and most intraregional variation in canine 
seroprevalence can be explained by human population density, habitat type, temperature, 
and precipitation. Deciduous and mixed forests in the region provide ideal habitat and 
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microenvironments to support I. scapularis populations and represent areas of high risk 
for infection.  Moreover, canine seroprevalence using specific assays for B. burgdorferi 
accurately represents risk of human LB in this endemic area, although we would not 
expect the same to hold true in non-endemic areas or with less specific diagnostic tests. 
Routine annual testing of dogs for specific antibodies to B. burgdorferi furthers 
understanding of both human and canine exposure risk and likely minimizes the bias 
inherent in estimating risk by human case reports alone.  
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Table 1: Environmental and social variables compared to percent positive canine tests 
and human case reports of Lyme borreliosis 
Factor p-value for 
percent 
positive 
canine 
tests 
R2 for 
percent 
positive 
canine 
tests 
p-value for 
human case 
reports of 
Lyme 
borreliosis 
R2 for 
human case 
reports of 
Lyme 
borreliosis 
Canine percent 
positive 
NA NA <0.00001 0.47 
Human cases of LB/ 
105 people 
<0.00001 0.47 NA NA 
Population Density 0.044 0.14 0.1012 0.09 
Income 0.1646 0.07 0.1182 0.08 
Minimum 
Temperature- 
November 
<0.00001 0.70 0.0002 0.39 
Maximum 
Temperature- 
November 
<0.00001 0.55 0.0029 0.27 
Precipitation-
November 
0.1846 0.06 0.6065 0.01 
Normalized Difference 
Vegetation Index 
(NDVI)- November 
0.0003 0.37 0.0126 0.20 
Open Water 0.1454 0.07 0.2529 0.05 
Developed- Open 
Space 
0.3032 0.04 0.1226 0.08 
Developed- Low 
Intensity 
0.0001 0.44 0.0009 0.33 
Developed- Medium 
Intensity 
<0.00001 0.68 0.002 0.29 
Developed- High 
Intensity 
0.0022 0.29 0.0461 0.13 
Barren Land 0.2574 0.05 0.4635 0.02 
Deciduous Forest <0.00001 0.78 0.0003 0.38 
Evergreen Forest 0.2861 0.04 0.3632 0.03 
Mixed Forest 0.0017 0.30 0.2086 0.06 
Shrub/Scrub 0.2727 0.04 0.002 0.29 
Grassland/Herbaceous 0.4696 0.02 0.6411 0.008 
Pasture/Hay 0.0017 0.30 <0.00001 0.68 
Cultivated Crops 0.1456 0.07 0.173 0.07 
Woody Wetlands 0.0731 0.11 0.9843 0.000 
Emergent Herbaceous 
Wetlands 
0.0133 0.20 0.094 0.10 
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Table 2: Backward stepwise regression analyzing environmental and social variables 
against percent positive canine tests  
R                              R Square                      Adjusted R 
Square              
p-level > F                   
0.9601 0.9218 0.9014 1.364e-11 
VAR                            Beta                          B                             p-level > t                   
Human case reports of 
LB per 105                 
0.3403 0.0263 0.0002 
Population Density            0.2556 0.00001 0.0044 
Maximum 
Temperature- 
November 
0.2766 0.0187 0.0495 
Deciduous Forest 0.8209 31.6845 0.000005 
Mixed Forest 0.3797 76.9569 0.0002 
Precipitation-November 0.223 0.0051 0.0021 
Constant                       -68.887                                                               
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Table 3: Backward stepwise regression analyzing environmental and social variables 
against human case reports of Lyme borreliosis. 
 
  
R                    R Square             Adj R Square    p-level > F          
0.8706 0.7579 0.7399 4.83E-09 
VAR                  Beta                 B                    p-level > t          
Percent  positive 
canine tests            
0.3395 4.4046 0.0058 
Pasture/ Hay      0.6366 1316.1 5.83E-06 
Constant             -39.9383                                           
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Figure 1. Evidence of antibody to Borrelia burgdorferi in dogs by county in the New 
York City Metropolitan Statistical Area, grouped according to percent positive tests. 
Counties are labeled with 2 letter abbreviations and were coded as follows: 0 – 5% 
(light blue), 6 – 10% (blue), 11 – 20% (dark blue), and > 20% (very dark blue). 
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Figure 2. Predicted and observed percent positive canine tests for each county.  
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Figure 3. Predicted and observed human case reports for each county.  
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CHAPTER V 
 
 
CANINE INFECTION WITH BORRELIA BURGDORFERI, DIROFILARIA 
IMMITIS, ANAPLASMA SPP., AND EHRLICHIA SPP. IN CANADA, 2013–20141 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Herrin, B.H., Peregrine, A.S., Goring, J., Beall M.J, Little S.E. 
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ABSTRACT 
Background. Canine test results generated by veterinarians throughout Canada 
from 2013–2014 were evaluated to assess the geographic distribution of canine infection 
with Borrelia burgdorferi, Dirofilaria immitis, Ehrlichia spp., and Anaplasma spp. 
Methods. The percent positive test results of 115,636 SNAP® 4Dx® Plus tests from 
dogs tested annually were collated by province and municipality to determine the 
distribution of these vector-borne infections in Canada. Results. A total of 2,844/115,636 
(2.5%) dogs tested positive for antibody to B. burgdorferi. In contrast, positive test 
results for D. immitis antigen and antibodies to Ehrlichia spp. and Anaplasma spp. were 
low, with less than 0.5% of dogs testing positive for any one of these three agents 
nationwide. Provincial seroprevalence for antibodies to B. burgdorferi ranged from 0.5% 
(Saskatchewan)–15.7% (Nova Scotia); the areas of highest percent positive test results 
were in close proximity to regions in the United States considered endemic for Lyme 
borreliosis, including Nova Scotia (15.7%) and eastern Ontario (5.1%). These high 
endemic foci, which had significantly higher percent positive test results than the rest of 
the nation (P< 0.0001), were surrounded by areas of moderate to low seroprevalence in 
New Brunswick (3.7%), Quebec (2.8%), and the rest of Ontario (0.9%), as well as 
northward and westward through Manitoba (2.4%) and Saskatchewan (0.5%). 
Insufficient results were available from the westernmost provinces, including Alberta and 
British Columbia, to allow analysis. Conclusion. Increased surveillance of these vector-
borne disease agents, especially B. burgdorferi, is important as climate, vector range, and 
habitat continue to change throughout Canada. Using dogs as sentinels for these 
pathogens can aid in recognition of the public and veterinary health threat that each pose. 
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BACKGROUND 
 Vector-borne diseases are an emerging concern for veterinarians and physicians in 
much of Canada. The prevalence of vector-borne infections, including Lyme borreliosis 
(LB), is increasing, apparently due to changing environmental and climatic conditions 
(Simon et al., 2014; Ogden et al., 2014; Eisen et al., 2016). Lyme borreliosis, heartworm, 
anaplasmosis, and ehrlichiosis are four common vector-borne diseases that are regularly 
diagnosed in dogs in the United States (Bowman et al., 2009). Determining the range and 
prevalence of the agents that cause these diseases throughout Canada may enhance 
awareness of their importance, encouraging preventive measures and leading to prompt, 
accurate diagnosis and appropriate treatment.  
Canine LB in North America is caused by infection with the spirochete Borrelia 
burgdorferi sensu stricto; other LB agents reported from people have not been identified 
in dogs. Disease in dogs is characterized by fever, lethargy, anorexia, and 
lymphadenopathy, but can progress to more severe manifestations such as arthritis and 
glomerulonephritis (Krukpa and Straubinger, 2010). Transmission to humans and dogs is 
by Ixodes sp. ticks; I. scapularis is the vector for the eastern half of Canada and I. 
pacificus the most important vector in British Columbia (Ogden et al., 2008). Ticks 
harboring B. burgdorferi have been identified throughout central and eastern Canada, 
including parts of Manitoba, Ontario, Quebec, Nova Scotia, and New Brunswick (Ogden 
et al., 2006). LB-endemic areas of Canada are defined as locations where all three life-
stages of the tick (larva, nymph, adult) have been collected for 2 consecutive years and B. 
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burgdorferi infection has been confirmed in ticks or vertebrate hosts (Health Canada, 
1991). LBis the most commonly reported vector-borne disease of people in the United 
States (CDC, 2015); approximately 25,000 cases are reported each year in the US, while 
in Canada, approximately 700 new cases were reported in 2015 (Public Health Agency of 
Canada, 2015; Hatchette et al., 2015 EID). This higher risk of infection in the US is also 
seen in pet dogs.  Over 7% of dogs tested from 2012 – 2014 were positive for antibodies 
to B. burgdorferi in the United States (Little et al., 2014). In contrast, only 0.7% and 
2.1% of dogs were reported to test positive in Canada in 2008 – 2010, respectively 
(Villeneuve et al., 2011; Qurollo et al., 2014).  
Dirofilaria immitis, causative agent of canine heartworm disease, is considered 
the most important helminth infection of dogs in the United States (Bowman et al., 2009). 
Mosquito vectors acquire D. immitis microfilariae when feeding on infected dogs and 
transmit the third-stage larvae, which then migrate and develop within dogs (Kotani and 
Powers, 1982; Kume and Itagaki, 1955).  The presence of adult heartworms in the 
pulmonary vasculature is a potential source of significant pathology (Jackson, 1974; 
Ishihara et al., 1978; Atwell et al., 1995). Heartworm infection has been reported in dogs 
in Canada since 1977, but the prevalence has remained relatively low at around 0.2% 
(Slocombe et al., 1993; Villeneuve et al., 2011). Because heartworm has historically been 
relatively uncommon in the region, most Canadian veterinary parasitologists recommend 
a seasonal preventive strategy. In addition, yearly testing is recommended for patients in 
high risk groups, including dogs who travel to endemic areas or those not receiving any 
preventive, or those on a preventive with poor compliance (Klotins et al., 2000 CanVetJ). 
Interestingly, over 77% of dogs that tested positive for infection with D. immitis in one 
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report had no travel history outside the region, supporting autochthonous infection, albeit 
at a low level (Villeneuve et al., 2011).  
 The rickettsial agents Anaplasma phagocytophilum, A. platys, Ehrlichia canis, 
and E. ewingii are all tick-borne bacterial pathogens infecting leukocytes of their host 
(Rikihisa 1991). These agents induce similar clinical signs and laboratory findings 
ranging from fever, anorexia, myalgia, and thrombocytopenia to severe manifestations 
such as epistaxis and death (Rikihisa, 1991).  
 Anaplasma phagocytophilum is transmitted through the bite of an Ixodes spp. tick, 
and is the causative agent of human granulocytic anaplasmosis (HGA) (Rikihisa, 2006). 
Previous canine serologic surveys in Canada have reported that the prevalence of dogs 
with antibodies to A. phagocytophilum is rising, with no dogs testing positive in 2006 but 
a prevalence ranging between 0.2% – 1.1% just five years later (Gary et al., 2006; 
Villenueve et al., 2011; Qurollo et al., 2014).  Anaplasma platys, causative agent of 
canine cyclic thrombocytopenia, is transmitted by Rhipicephalus sanguineus and infects 
platelets of dogs (Harvey et al., 1978; Harvey, 2006). In a previous study, 1.8% of dogs 
tested in Canada were reported to have antibodies to A. platys (Qurollo et al., 2014).  
Ehrlichia canis is the causative agent of canine monocytic ehrlichiosis, and is also 
transmitted by R. sanguineus; infection causes anemia, thrombocytopenia, and, in severe 
cases, potentially fatal bleeding diathesis (Harrus and Waner; Neer and Harrus, 2006). 
Ehrlichia ewingii is the causative agent of canine granulocytic ehrlichiosis and is 
transmitted by Amblyomma americanum. The range of A. americanum has dramatically 
expanded northward and eastward in recent decades (Springer, 2014). While A. 
americanum populations are not yet considered established in Canada, the tick is 
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occasionally reported from domestic dogs in Ontario with no travel history out of the 
region (Peregrine unpublished). Of the two, only E. canis has been reported in Canada 
previously, with 3.2% of dogs tested having antibodies to the pathogen, while 0/285 dogs 
tested positive for Ehrlichia chaffeensis or E. ewingii (Qurollo et al., 2014).  
 Evidence of past or current infection with all of these pathogens can be identified 
with assays commonly used for annual heartworm testing and as a screening tool for tick-
borne infections, and the composite results can be evaluated on both a local and national 
level. For example, by reviewing the changing prevalence of antibody-positive dogs over 
time, previously undocumented areas of expansion of LB were detected (Bowman et al., 
2009; Little et al., 2014). The present paper seeks to build on previous publications 
(Villeneuve et al., 2011; Qurollo et al., 2014), potentially identifying areas of recent 
expansion of LB as well as monitoring the overall distribution of these vector-borne 
infections in Canada. 
 
MATERIALS AND METHODS 
Source of data 
 The data collected were obtained from the SNAP® 4Dx® Plus Test kit (IDEXX 
Laboratories, Inc., Westbrook, Maine), an in-clinic ELISA for the simultaneous detection 
of canine antibodies to B. burgdorferi, A. phagocytophilum, A. platys, E. canis, and E. 
ewingii, and antigen of D. immitis. The results were generated from January 2013 through 
December 2014 by veterinarians testing patients in-clinic, mainly during routine annual 
wellness examination, and recording the data manually or by IDEXX SnapShot Dx® 
instrumentation. For privacy, results were provided with no patient or owner 
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identification, therefore travel history, confirmatory diagnostics, and clinical outcome for 
each result is not known.  
Borrelia burgdorferi assay 
The analyte utilized for the B. burgdorferi assay is the C6 peptide, which detects 
antibodies to a surface lipoprotein of B. burgdorferi sensu stricto. The sensitivity and 
specificity of the analyte is reported in the package insert to be 94.1% and 96.2% 
(IDEXX Laboratories, Inc., Westbrook, ME), respectively, but published studies with 
different populations report different values. For example, in comparison to a two-tiered, 
gold standard diagnostic process utilizing immunofluorescence (IFA) and Western blot 
(WB), the test sensitivity was 94.4% (O’Connor, 2004; Chandrashekar, 2010), and the 
test specificity has been reported to be 99.5% when used on field samples from dogs 
(O’Connor, 2004; Duncan, 2004). The C6 analyte has also been shown to not cross-react 
with other Borrelia spp. found in the US or react to antibodies produced through 
vaccination (O’Connor, 2004)  
Heartworm assay 
 The assay utilized detects D. immitis antigen primarily produced from the uterus 
of female heartworms. The sensitivity and specificity reported for the heartworm portion 
of the assay is 99.0% and 99.3%, respectively (IDEXX Laboratories, Inc., Westbrook, 
ME). Other studies have reported the sensitivity of this analyte as 84%, but that value 
varies with intensity of infection, with a sensitivity of 64% when only one adult, female 
heartworm is present and 98% when 4 or more adult heartworms are present 
(Chandrashekar, 2010; Atkins, 2003).  
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Anaplasma assay 
 Analytes were used that detect antibodies to a peptide from the MSP2/p44 major 
surface protein of two distinct Anaplasma spp.: A. phagocytophilum and A. platys. 
Detection of A. platys was added after recognizing significant cross-reactivity (SNAP® 
4Dx® Test kit insert, IDEXX Laboratories, Inc., Westbrook, ME). The reported 
sensitivity and specificity of the test are 90.3% and 94.3%, respectively (IDEXX 
Laboratories, Inc., Westbrook, ME). The sensitivity of the assay is 99.1% for A. 
phagocytophilum and 89.1% for A. platys when compared to IFA, while the specificities 
are reported as 100% and 99.8% respectively, although sensitivity and specificity against 
field samples may vary (Chandrashekar, 2009; Stillman 2014).      
Ehrlichia assay 
 Analytes were used that detect antibodies to the p30 and p30-1 proteins of E. 
canis and the p28 protein of E. ewingii. The reported sensitivity and specificity of this 
assay is 97.1% and 95.3%, respectively (IDEXX Laboratories, Inc., Westbrook, ME). In 
other studies, when compared to IFA or WB, the sensitivity was 95.7% for E. canis and 
96.5% for E. ewingii (O’Connor, 2002; Stillman, 2014). The test specificity for E. canis 
has been shown to be 100% (O’Connor, 2004, 2006), while specificity for the detection 
of antibodies to E. ewingii is 93.9% (Stillman, 2014). Infection with other Ehrlichia spp. 
may induce cross-reactive antibodies leading to a positive test result on the Ehrlichia spp. 
analyte (O’Connor, 2004; Hegarty et al., 2012).  
Data and statistical analysis 
Data were collated by three-digit postal code of the veterinary practice where the 
test was performed, and then assembled into municipalities or major metropolitan areas 
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and provinces. Only municipalities reporting more than 30 test results were included in 
the study. Percent positive test results were calculated by dividing the number of dogs 
with a positive test result by the total number of test results reported for each agent of 
interest. For all samples, 95% confidence intervals were calculated using the modified 
Wald method (GraphPad Software, La Jolla, CA).  Maps were assembled using the 
Canada base map and the Hatch Map function on MapViewer 7 (Golden Software, 
Golden, CA). 
 Differences in reported frequency of positive test results between municipalities 
and provinces were evaluated using a Chi-square test in StatPlus (Windows 7, Redmond, 
WA; AnalystSoft, Alexandria, VA) with significance assigned at P< 0.0001 as previously 
described (Bowman, 2009).  
 
RESULTS 
Summary 
 Test results were available from a total of 225 practices in 2013 and 198 practices 
in 2014, representing 115,636 data points from 84 different municipalities across Canada. 
Ontario reported the highest number of test results (77,143) followed by Quebec 
(23,701), Manitoba (12,765), New Brunswick (1,631), Nova Scotia (210), and 
Saskatchewan (186). All other provinces and territories had fewer than 30 test results 
reported in a single municipality.  
Borrelia burgdorferi 
 The prevalence of antibody positive dogs nationwide was 2.5% (2,844/115,636) 
with provincial prevalence ranging from 0.5 – 15.7%. Over half (44/84 of the 
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municipalities reported 2% or greater positive test results, while 7 reported less than 0.5% 
positive test results. Positive test results for antibodies to B. burgdorferi were most 
common in Nova Scotia, with 15.7% of samples from this province testing positive, 
which was higher than the national average (P< 0.00001). Other provinces had percent 
positive test results higher than the national average, including New Brunswick (3.7%; 
P=0.001), and Quebec (2.8%; P<0.00001). Ontario had a lower overall seroprevalence 
than the national average (2.3%; P<0.00001), but in a cluster of 11 municipalities in 
eastern Ontario more than 5.1% (1,335/26,081; P<0.00001) of dogs tested positive.  
Dirofilaria immitis 
Nationwide, 0.42% (485/115,636) of dogs tested positive for heartworm antigen, 
and no province had percent positive test results greater than 0.5% (0-0.5%). Ontario had 
the highest percent positive tests (0.50%). Two municipalities had percent positive test 
results higher than 2%: Mirabel in Quebec (5.0%; 2/40; 95% CI 0.50% – 17.4%) and 
Caledonia in Ontario (4.1%; 207/5,111; 95 % CI 3.5% – 4.6%). Both of these 
municipalities had a higher prevalence than the national average and the rest of the 
respective province (P<0.00001).  
Anaplasma spp. 
 Antibody to Anaplasma spp. was detected in 0.29% (331/115,636) of dogs, with a 
provincial seroprevalence ranging from 0.0 – 0.95%. Nova Scotia and Manitoba were the 
only provinces that had a higher prevalence than the national average with 0.95% and 
0.86% of all tests reported positive, respectively; the total number of positive tests in 
municipalities within these provinces that had a seroprevalence above 1.0% ranged 
between 2 and 12 positive tests. Percent positive test results in Ontario were significantly 
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lower than the national average at 0.22% (P<0.00001); no municipalities in Ontario had 
percent positive test results over 1.0%. 
Ehrlichia spp. 
 Antibody to Ehrlichia spp. was identified in 0.19% of tests with a range among 
the provinces of 0-1.6%. Saskatchewan had the highest seroprevalence of any province 
(1.6%;  P<0.00001). A total of 4 municipalities across Canada had a reported 
seroprevalence higher than 1%; Saskatoon in Saskatchewan (1.6%; 3/186; 95% CI 0.33% 
– 4.9%), Hampton in New Brunswick (1.3%; 2/152; 95% CI 0.06% – 5.0%), and Bruce 
and Port Hope in Ontario (1.2%; 3/250; 95% CI 0.24% – 3.6% and 1.0%; 6/590; 95% CI 
0.41% – 2.2% respectively). 
  
DISCUSSION 
 The dataset in the present paper was obtained from veterinarians in practice and 
allowed us to determine the prevalence of four vector-borne infections throughout 
Canada. As reported in previous studies, the data are biased towards major population 
centers where the majority of dogs and dog owners reside (Little et al., 2014). While the 
prevalence of positive tests for heartworm antigen and antibody to Ehrlichia spp. and 
Anaplasma spp. were low in all provinces, there was evidence of past or current infection 
with at least one of these agents in every province reporting data (Table 1 and Figs. 1-4).  
 Percent positive tests for antibodies to B. burgdorferi were higher in the present 
study than reported in 2011 (0.72%; P<0.00001), but not significantly different than more 
recent reports (2.1%; P=0.70) (Villeneuve et al., 2011; Qurollo et al., 2014). Moderate 
(>1%) or high (>5%) percent positive tests in dogs were identified in areas with frequent 
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reports of human LB and where surveillance of ticks has confirmed the presence of B. 
burgdorferi (Werden et al., 2015; Hatchette et al., 2015; Ogden et al., 2010; Gabrielle-
Rivet et al., 2015). These areas are also in close proximity to the northeastern or upper 
midwestern regions of the United States where LB is endemic or hyperendemic (Little et 
al., 2014). While the prevalence of B. burgdorferi-specific antibodies ranged from 0.5-
15% for different provinces, there were also four municipalities with percent positive test 
results above 20%, the highest of which was Pictou County, Nova Scotia at 40.6%  
(13/32). Areas such as Pictou County, southern Quebec, and eastern Ontario appear to 
constitute hyperendemic foci (>5% positive tests) with a declining prevalence radiating 
outward. This effect is likely exaggerated by human population clusters in southern 
Ontario, but can also represent true foci of increased infection risk including the 11 
municipalities in eastern Ontario where the seroprevalence is 5.1% versus the rest of the 
province with a seroprevalence of 0.87% (P<0.00001).  
 Positive test results for heartworm antigen were most commonly seen near major 
population centers like Montreal and Toronto, with the rest of the municipalities 
reporting a prevalence of  < 2% (Fig 2). This urban-centered phenomenon is common in 
heartworm ecology in the US as domestic dogs serve as the major reservoir for infection 
of mosquitoes and large cities may harbor “heat islands” that create more favorable 
biologic conditions for the mosquitoes as compared to the surrounding rural areas (Paras, 
2014).  While the total prevalence across Canada was quite low (0.42%) in the present 
paper, it was significantly higher than the previously described prevalence of 0.22% 
(P<0.00001) (Villenueve, 2011). Other studies have shown that heartworm prevalence in 
dogs in Canada has remained stable at approximately 0.2% over the last 30 years 
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(Klotins, 2000). This apparent doubling in prevalence over the last 5 years may indicate 
increased testing of dogs in which infection is suspected. Alternatively, it could reflect a 
northward expansion of mosquito vectors due to changes in climate patterns in the region 
(Ogden, 2014).   
 The analyte for Anaplasma spp. detects antibodies to both A. phagocytophilum 
and A. platys. Anaplasma phagocytophilum is transmitted by I. scapularis, like B. 
burgdorferi, and thus when mapped these two tick-borne infections often co-localize 
(Little et al., 2014). Some correlation between the two test results can be seen in this 
dataset, but it was not as strong as expected (Pearson’s Correlation Coefficient ρ=0.34). 
While the municipalities with the highest Anaplasma spp. seroprevalence (>2.0%) were 
associated with B. burgdorferi seroprevalence over 4.8% (ρ=0.6), the municipalities with 
the highest prevalence of antibodies to B. burgdorferi (>10%) did not correspond to high 
Anaplasma spp. seroprevalence (>1%) (ρ=0.17). Anaplasma phagocytophilum appears to 
circulate in nature at a lower level than B. burgdorferi, and detection of this pathogen in 
newly endemic areas may be difficult (Werden, 2015; Bowman, 2009; Little, 2014; 
Dahlgren 2015). The assays used in the present paper also detect antibody to A. platys 
and it is not possible to differentiate that response from antibody to A. phagocytophilum. 
Reports of R. sanguineus, the vector for A. platys, are rare in Canada with less than 20 
ticks reported per year in Ontario, in comparison to I. scapularis, which averages over 
1,000 submissions each year (Nelder et al 2014). Nonetheless, confirmed cases of A. 
platys in Canada have been reported as co-infections with E. canis and explained by 
travel to areas where R. sanguineus are more common (Al Izzi 2013).  
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 Antibodies to Ehrlichia spp. were least commonly detected in the present study, 
likely due to a dearth of vector ticks in the region. As for A. platys, the risk for 
autochthonous transmission of E. canis by R. sanguineus in Canada is low, although 
travel cases may be diagnosed and reported (Al Izzi 2013). Similarly, A. americanum, the 
vector of E. ewingii and E. chaffeensis, is still considered rare in this area of North 
America (Springer 2014; Nelder et al 2014). Interestingly, the majority of positive tests 
for antibodies to Ehrlichia spp. were in southwestern Ontario, directly adjacent to the 
Midwest region of the United States that has now described Ehrlichia muris-like agent 
(EMLA) as a new I. scapularis-transmitted pathogen (Johnson EID 2015). While more 
research is needed, existing data suggest antibodies to EMLA may be cross-reactive with 
existing assays for Ehrlichia spp. antibodies including that used in the present paper 
(Hegarty et al., 2012). Although the natural maintenance cycle is not fully defined, 
EMLA has been identified in I. scapularis and white-footed mice (Peromyscus leucopus) 
(Saito 2015; Castillo 2015).  
 When nationwide data are collected, as in this study, there are limitations to the 
utility and interpretation of the data. Reporting bias, travel history, and detection method 
all factor into the prevalences presented (Bowman et al., 2009). In regions where low 
numbers of total tests are being reported, veterinarians may be using the SNAP® 4Dx® 
Test kit as a targeted diagnostic test rather than an annual wellness screening tool, a 
factor which may explain the high seroprevalence to B. burgdorferi reported from Nova 
Scotia (Table 1). Unfortunately, the current lack of data in western Canada prevents 
analysis in that region despite confirmation that B. burgdorferi is endemic in the 
northwestern United States and in British Columbia (Morshed et al., 2015). It should also 
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be noted that the low number of test results available in some areas and the low positive 
predictive values in low prevalence populations complicate interpretation (Peregrine 
2005; Peregrine 2007).  
 This nationwide data can aid veterinarians in making informed decisions on 
annual canine wellness procedures that would be most beneficial, including acaricide use, 
heartworm prevention, and vaccination for B. burgdorferi, and when evaluated over time, 
the results can help document the changing distribution of vector-borne infections 
(Bowman et al., 2009, Little et al., 2014). Finally, these vector-borne pathogens have 
been documented to cause disease in humans, and mapping the risk of canine infection 
also describes the areas where humans are most likely to be infected (Duncan et al., 2005; 
Schurer JM 2014; Gaito 2014). Further prevalence studies are warranted to investigate 
regions with no data at present and to provide updates on the changing distribution of 
these infections, particularly as they become newly endemic.  
 
CONCLUSIONS 
 This study serves as an update on the positive test results for common vector-
borne infections in dogs, in Canada.  Antibodies to B. burgdorferi were most commonly 
identified; the prevalence of infection in many provinces and the national average was 
higher than previously reported. While still low, percent positive D. immitis antigen tests 
were twice that reported 20 years ago, suggesting an increase in prevalence of mosquito-
borne heartworm. Infections with Anaplasma spp. and Ehrlichia spp. appear to remain 
fairly uncommon throughout Canada. While the work described here did not control for 
travel or false positives, canine serology is a key tool for monitoring vector-borne 
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infections on a large scale and can be used to track the geographic spread of these agents 
and assess public health risks over time. Collectively, the data support efforts by 
veterinarians and physicians to protect pets and people from an increasing threat of 
vector-borne infections.  
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Table 1. Vector-borne infections in dogs in Canada, 2013–2014  
Province 
Number of tests 
Borrelia 
burgdorferi 
%  
(95% CI) 
Number positive 
Dirofilaria 
immitis 
%  
(95% CI) 
Number 
positive 
Anaplasma 
spp. 
%  
(95% CI) 
Number 
positive 
Ehrlichia 
spp. 
%  
(95% CI) 
Number 
positive 
Manitoba 
n = 12,765 
2.4% 
(2.1 – 2.7) 
0.20% 
(0.12 – 0.28) 
0.86% 
(0.70 – 1.0) 
0.24% 
(0.16 – 0.32) 
303 26 110 31 
New Brunswick 
n = 1,631 
3.7% 
(2.9 – 4.7) 
0.12% 
(0.01 – 0.48) 
0.43% 
(0.19 – 0.90) 
0.12% 
(0.01 – 0.48) 
60 2 1 2 
Nova Scotia 
n = 210 
15.7% 
(11.4 – 21.3) 
0.48% 
(0.01 – 2.9) 
0.95% 
(0.04 – 3.6) 
0% 
(0.00 – 2.2) 
33 1 2 0 
Ontario 
n = 77,143 
2.3% 
(2.2 – 2.4) 
0.50% 
(0.45 – 0.55) 
0.22% 
(0.19 – 0.25) 
0.19% 
0.16 – 0.22) 
1780 385 166 146 
Quebec 
n = 23,701 
2.8% 
(2.6 – 3.0) 
0.30% 
(0.23 – 0.37) 
0.19% 
(0.13 – 0.25) 
0.16% 
(0.11 – 0.21) 
667 71 46 37 
Saskatchewan 
n = 186 
0.54% 
(0.01 – 3.3) 
0% 
(0.00 – 2.4) 
0% 
(0.00 – 2.4) 
1.6% 
(0.33 – 4.9) 
1 0 0 3 
National 
n = 115,636 
2.5% 
(2.4 – 2.6) 
0.42% 
(0.38 – 0.46) 
0.29% 
(0.26 – 0.32) 
0.19% 
(0.16 – 0.22) 
2,844 485 331 219 
Percent positive test results, (95% Confidence Intervals (CI)), and total number positive 
by province for dogs tested from 2013 – 2014 for antigen of Dirofilaria immitis and 
antibody to Borrelia burgdorferi, Ehrlichia spp., and Anaplasma spp.  
  
149 
 
Figure 1. Percent positive antibody tests to Borrelia burgdorferi in dogs by 
municipality.  
 
Evidence of antibody to Borrelia burdorferi in dogs by municipality throughout Canada, 
2013 – 2014, grouped according to percent positive tests. 
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Figure 2. Percent positive antigen tests of Dirofilaria immitis in dogs by municipality.  
 
Evidence of antigen of Dirofilaria immitis in dogs by municipality throughout Canada, 
2013 – 2014, grouped according to percent positive tests. 
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Figure 3. Percent positive antibody tests to Anaplasma spp. in dogs by municipality.  
 
Evidence of antibody to Anaplasma spp. in dogs by municipality throughout Canada, 
2013 – 2014, grouped according to percent positive tests. 
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Figure 4. Percent positive antibody tests to Ehrlichia spp. in dogs by municipality.  
 
Evidence of antibody to Ehrlichia spp. in dogs by municipality throughout Canada, 2013 
– 2014, grouped according to percent positive tests.
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CHAPTER VI 
 
 
CONCLUSIONS 
Serologic monitoring for common vector-borne diseases of dogs, including Lyme 
borreliosis (LB), has been commonly pursued in veterinary practices over the last 10 
years (Bowman et al., 2009; Villenueva, 2011; Little et al., 2014; Qurollo et al., 2014).   
Current survey data for antibodies to Borrelia burgdorferi in this region show dogs in the 
Upper Midwest and Northeast regions of the US and Southeast Canada are more 
commonly infected with B. burgdorferi when compared to dogs from other areas 
(Bowman et al., 2009; Villenueva, 2011; Little et al., 2014; Qurollo et al., 2014). The 
overarching goal of the research reported in this dissertation was to use canine serology 
as a tool to further characterize the LB-endemic regions of North America.  
 The goal of the first study was to determine if the range of Ixodes scapularis ticks 
harboring B. burgdorferi had expanded into southwestern Virginia. Changes in canine 
antibody prevalence to B. burgdorferi in the region suggested the endemic range of the 
pathogen had spread southward along the Appalachian Mountains (Bowman et al., 2009; 
Little et al., 2014). Of 364 ticks collected, all were confirmed to be I. scapularis. In 
addition, 33% of ticks tested positive for B. burgdorferi sensu stricto by PCR. Both the 
tick population and the prevalence of pathogen within them are consistent with LB-
endemic areas historically considered to be limited to the Northeast. These data not only
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 show the expansion of I. scapularis and B. burgdorferi southward, but also highlight the 
utility of canine serology to inform targeted tick testing to confirm the expansion of both 
the bacteria and its vector.   
 The second study sought to define the social and environmental factors associated 
with human case reports and canine seroprevalence of B. burgdorferi infections in the 
New York City Metropolitan Area. Previous studies have shown that canine serology to 
B. burgdorferi correlates with human case reports and can be used to describe areas 
where humans are likely to become infected (Duncan et al, 2005; Mead et al., 2011).  
Also, environmental factors have be used to predict areas where both humans and dogs 
are likely to become infected, but previously, no studies have analyzed which reporting 
method would be most useful in describing the environments most suited for increased 
risk of infection (Messier et al., 2016; Guerra et al., 2001). As expected, the case reports 
and prevalence of positive antibody tests increased with increasing forested area, become 
progressively higher as distance from the more densely populated regions increased. 
Furthermore, a more complete description of environmental factors related to risk of 
infection, including mixed and deciduous forest, precipitation, and maximum 
temperature, was developed by comparing to canine serology positive tests (adjusted R2= 
0.90). This study highlighted the utility of canine serology as an additional factor to help 
accurately describe the endemic areas of LB in North America. 
 The final study involved continued surveillance of canine vector-borne infections 
in Canada. Previous research in Canada has documented low seroprevalence to common 
vector-borne infections including B. burgdorferi, Dirofilaria immitis, Anaplasma spp., 
and Ehrlichia spp., but as climate and environmental factors change these infections are 
 155 
expected to become more common (Villenueve et al., 2011; Qurollo et al., 2014). Overall 
seroprevalence of antibodies to B. burgdorferi was 2.5%, while the prevalence of the 
other agents was below 0.5% each. These data reaffirm the endemicity of LB in parts of 
southern and eastern Canada, including Nova Scotia, New Brunswick, Quebec, and 
Ontario, which all had canine antibody seroprevalence similar to LB endemic areas in the 
United States. Overall, this study showed the utility of continued surveillance of vector-
borne infections in dogs as vector populations in Canada continue to change over time.  
 In summary, continued surveillance of antibodies to B. burgdorferi in dogs can be 
beneficial to both canine and human health. Continued monitoring of canine 
seroprevalence to B. burgdorferi allows us to track the changing prevalence of infection 
over time as well as the geographic distribution, which we have documented provides the 
most accurate description of the true endemic range of the disease. Moreover, the data 
can also be used to describe those environments within that range that best support the 
bacteria, tick vector, and reservoir hosts to maintain the transmission cycle in nature. By 
combining all this information, we can make inferences on where the endemic range for 
LB may expand in the future, providing key information to aid medical professionals in 
the diagnosis of the disease in these areas.  
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